{"gene":"BMAL1","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2010,"finding":"GSK3β phosphorylates BMAL1 specifically on Ser17 and Thr21, priming it for ubiquitylation and proteasomal degradation. In the absence of GSK3β-mediated phosphorylation, BMAL1 is stabilized. Dopamine D2 receptor signaling via the Akt-GSK3β pathway regulates BMAL1 stability and circadian gene expression amplitude in striatal neurons.","method":"In vitro phosphorylation assays, site-directed mutagenesis (Ser17/Thr21), ubiquitylation assays, D2 receptor pharmacology in striatal neurons","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis identifying specific phosphorylation sites, combined with ubiquitylation assay and in vivo neuronal validation","pmids":["20049328"],"is_preprint":false},{"year":2014,"finding":"CLOCK:BMAL1 heterodimer functions as a pioneer-like transcription factor: it binds to nucleosomes, promotes rhythmic chromatin opening (including incorporation of histone variant H2A.Z), and enables rhythmic binding of other transcription factors at adjacent sites, thereby driving genome-wide heterogeneous transcriptional output.","method":"ChIP-seq, ATAC-seq (chromatin accessibility), histone variant profiling, genome-wide binding analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genome-wide ChIP-seq with chromatin remodeling assays, multiple orthogonal methods establishing pioneer function","pmids":["24395244"],"is_preprint":false},{"year":2020,"finding":"BMAL1 functions as a metabolic checkpoint in macrophages: upon M1 inflammatory stimulation, myeloid-specific Bmal1 KO renders macrophages unable to sustain mitochondrial function, enhancing succinate dehydrogenase (SDH)-mediated ROS production and HIF-1α-dependent metabolic reprogramming. This Bmal1-HIF-1α regulatory loop controls macrophage effector functions and tumor microenvironment.","method":"Myeloid-specific Bmal1 knockout (M-BKO), mitochondrial function assays, ROS measurement, HIF-1α activation assays, SDH inhibitor rescue experiments, tumor burden measurement","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple orthogonal metabolic readouts, genetic and pharmacological rescue, replicated in inflammatory and tumor contexts","pmids":["32396064"],"is_preprint":false},{"year":2025,"finding":"BMAL1 forms a transcriptionally active heterodimer with HIF2A (a non-canonical partner) in a diurnal manner to regulate myocardial hypoxic response. Cryo-EM structure of the BMAL1-HIF2A-DNA complex reveals structural rearrangements within BMAL1 that enable circadian-hypoxia cross-talk. BMAL1 enhances HIF2A transcriptional activity and stabilizes the HIF2A protein. Amphiregulin (AREG) is identified as a rhythmic target of this complex, critical for daytime variations in myocardial injury.","method":"Cryo-EM structure determination, Co-IP, transcriptional activity assays, HIF2A protein stability assays, ChIP, cardiac ischemia models with time-of-day pharmacological targeting","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure plus biochemical validation of heterodimer, protein stabilization, and downstream target identification in a single rigorous study","pmids":["40269168"],"is_preprint":false},{"year":2018,"finding":"The nuclear receptor HNF4A strongly transrepresses the transcriptional activity of the CLOCK:BMAL1 heterodimer and maintains cell-autonomous circadian oscillations in a tissue-specific manner in liver and colon cells. Genome-wide ChIP-seq reveals co-occupancy of HNF4A and CLOCK:BMAL1 at metabolic genes, defining a feedback loop in tissue-specific oscillators.","method":"Luciferase transcriptional activity assays, ChIP-seq (genome-wide co-occupancy), siRNA knockdown of HNF4A in liver and colon cells, circadian period measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal transcriptional assays plus genome-wide ChIP-seq, two orthogonal methods, single lab","pmids":["30530698"],"is_preprint":false},{"year":2022,"finding":"BMAL1 plays a transcription-independent role in stabilizing heterochromatin to prevent activation of the LINE1-cGAS-STING pathway. In senescent primate mesenchymal progenitor cells (MPCs), BMAL1 binding to LINE1 loci is decreased, leading to heterochromatin destabilization and aberrant LINE1 transcription, accelerating aging phenotype.","method":"BMAL1 loss-of-function in human and cynomolgus monkey MPCs, chromatin fractionation, ChIP for BMAL1 at LINE1, cGAS-STING pathway activation assays, heterochromatin marker analysis in BMAL1-deficient monkey tissues","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — primate model with multiple orthogonal methods (ChIP, fractionation, pathway assays) in both cell and tissue contexts, establishes non-canonical chromatin function","pmids":["35286396"],"is_preprint":false},{"year":2015,"finding":"BMAL1 in chondrocytes directs circadian expression of catabolic, anabolic, and apoptotic genes critical for cartilage homeostasis. Loss of chondrocyte BMAL1 reduces phosphorylated SMAD2/3 and NFATC2, decreases expression of Sox9, Acan, and Col2a1, and increases p-SMAD1/5 levels, causing progressive cartilage degeneration.","method":"Chondrocyte-specific Bmal1 knockout mice, RNA-seq, western blot for SMAD2/3 and SMAD1/5 phosphorylation, histological cartilage assessment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with molecular pathway analysis (SMAD phosphorylation) and histological phenotype, multiple orthogonal readouts","pmids":["26657859"],"is_preprint":false},{"year":2020,"finding":"BMAL1 regulates macrophage actin cytoskeletal organization, motility, and phagocytosis via a RhoA-dependent mechanism. BMAL1-/- macrophages show reduced phosphocofilin, increased active RhoA, altered cell morphology and increased motility. BMAL1 controls a network of 148 cell movement genes within 100 kb of high-confidence BMAL1 binding sites, including 29 genes impacting RhoA expression or activation. RhoA inhibition restores phagocytic phenotype.","method":"Bmal1-/- macrophage characterization, phosphoproteomics, RhoA activity assay, phagocytosis assay in vivo and in vitro, RhoA inhibitor rescue, BMAL1 ChIP-seq for binding sites near cytoskeletal genes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — phosphoproteomics plus functional rescue plus ChIP-seq, multiple orthogonal methods establishing RhoA-mediated mechanism","pmids":["31900362"],"is_preprint":false},{"year":2023,"finding":"BMAL1 rhythmically localizes to hippocampal synapses in a manner dependent on its phosphorylation at Ser42 (pBMAL1-S42). Synaptic pBMAL1(S42) regulates autophosphorylation of CaMKIIα and circadian rhythms of CaMKIIα-dependent molecular interactions and LTP, but not global rest/activity behavior.","method":"Immunofluorescence/subcellular fractionation of synaptic BMAL1, phospho-specific antibodies, electrophysiology (LTP), CaMKIIα autophosphorylation assays, Ser42 phosphorylation-state analysis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Moderate — synaptic fractionation with phospho-site specificity, electrophysiological readout (LTP), and CaMKIIα biochemistry, multiple orthogonal methods in a single study","pmids":["37878694"],"is_preprint":false},{"year":2018,"finding":"P2-HNF4α (an alternative isoform induced in hepatocellular carcinoma) represses BMAL1 (ARNTL) expression and causes nuclear-to-cytoplasmic re-localization of P1-HNF4α. Forced BMAL1 expression in HNF4α-positive HCC prevents tumor growth in vivo.","method":"Promoter reporter assays, immunofluorescence for BMAL1 localization, forced BMAL1 expression in HCC xenografts, isoform-specific expression analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — localization and in vivo rescue experiments, but mechanistic details of repression rely on expression correlations in addition to functional assays","pmids":["30341289"],"is_preprint":false},{"year":2020,"finding":"Necdin stabilizes BMAL1 protein through SGT1-HSP90 chaperone machinery. Necdin interacts with BMAL1 (N-terminal fragment) and SGT1 (C-terminal fragment) as identified by yeast two-hybrid screening. Depletion of necdin or SGT1/HSP90 leads to BMAL1 degradation via the ubiquitin-proteasome system, altering clock gene expression and circadian rhythms.","method":"Yeast two-hybrid screening, Co-IP, domain mapping (N- and C-terminal fragments), HSP90 inhibitor treatment, proteasome inhibitor rescue, necdin-KO mouse behavioral and gene expression analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — yeast two-hybrid plus Co-IP plus proteasome inhibitor rescue plus KO phenotype, multiple orthogonal methods establishing chaperone-dependent stability mechanism","pmids":["32667666"],"is_preprint":false},{"year":2014,"finding":"BMAL1 deficiency leads to increased mTORC1 activity both in vivo and in cell culture. mTORC1 inhibition with rapamycin increases lifespan of Bmal1-/- mice by 50%, placing BMAL1 as a negative regulator of mTORC1 signaling upstream of aging control.","method":"Bmal1-/- mice, mTORC1 activity assays (S6K phosphorylation), rapamycin treatment, lifespan measurement","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with rapamycin rescue demonstrating epistasis, single lab","pmids":["24481314"],"is_preprint":false},{"year":2022,"finding":"The RRE-mediated feedback regulation of Bmal1 (rhythmic transcription driven by REV-ERB/ROR elements) underpins the E-box-mediated core oscillation. Deletion of RRE elements in mutant mice produced apparently normal rhythms but made circadian period and amplitude more susceptible to disturbance of CRY1 protein rhythm, demonstrating that rhythmic Bmal1 transcription confers perturbation resistance to the clock.","method":"CRISPR deletion of RRE elements in cells and mice, circadian period/amplitude measurements, mathematical modeling, CRY1 protein manipulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genetic deletion with modeling and experimental validation, established in both cells and whole animals","pmids":["35999195"],"is_preprint":false},{"year":2019,"finding":"BMAL1 coordinates circadian MRP2 expression in the intestine by directly activating transcription of Dbp and Rev-erbα through E-box elements in their promoters, which in turn regulate Mrp2 via a D-box element. BMAL1 also negatively regulates E4BP4 (a Mrp2 repressor) via Rev-erbα, generating diurnal Mrp2 expression and time-dependent drug pharmacokinetics.","method":"Intestine-specific Bmal1 KO mice, qPCR, western blot, luciferase reporter assays, EMSA, ChIP assays for E-box binding, intestinal perfusion and pharmacokinetic experiments","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — EMSA, ChIP, reporter assays plus in vivo pharmacokinetics in conditional KO, multiple orthogonal methods in single lab","pmids":["31244920"],"is_preprint":false},{"year":2019,"finding":"BMAL1 regulates circadian Cyp3a11 expression by directly activating Hnf4α and Dbp transcription via E-box elements. Cellular regulation of Cyp3a11 by BMAL1 is Dbp- and HNF4α-dependent, as Dbp activates and Hnf4α activates Cyp3a11 transcription via a D-box and DR1 element respectively in the Cyp3a11 promoter.","method":"Bmal1-deficient mice, luciferase reporter, ChIP, promoter mutation analysis, Dbp/Hnf4α overexpression/knockdown, drug toxicity assays","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP plus reporter plus mutagenesis plus in vivo KO, multiple orthogonal methods in single lab","pmids":["31633069"],"is_preprint":false},{"year":2018,"finding":"BMAL1 activates Sult1a1 transcription by directly binding an E-box element (-571 to -554 bp) in the Sult1a1 promoter, controlling circadian expression and activity of the sulfotransferase enzyme.","method":"Bmal1-deficient mice, luciferase reporter assay, EMSA, ChIP assay, serum-shocked cell circadian model","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — EMSA and ChIP plus reporter plus in vivo KO, single lab with multiple orthogonal methods","pmids":["30064996"],"is_preprint":false},{"year":2018,"finding":"CLOCK and BMAL1 cooperate to upregulate RHOA expression by inhibiting CUL3-mediated ubiquitination, and activate RHOA by reducing its interaction with RhoGDI. Consequently, CLOCK:BMAL1 controls the RHOA-ROCK-cofilin pathway, altering F-actin/G-actin dynamics and promoting cancer cell proliferation, migration, and invasion.","method":"Co-IP for RHOA-RhoGDI and CUL3 interactions, ubiquitination assay, F-actin/G-actin ratio measurement, CLOCK/BMAL1 overexpression and knockdown in cancer cells, cell migration and invasion assays","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus functional readouts, single lab with multiple orthogonal methods","pmids":["30287810"],"is_preprint":false},{"year":2016,"finding":"Hepatic BMAL1 controls lipoprotein production and biliary cholesterol excretion by regulating expression of Mtp and Abcg5/Abcg8 via Shp and Gata4. BMAL1 deficiency reduces SHP (increasing MTP and lipoprotein secretion) and reduces GATA4 (diminishing ABCG5/8 expression and biliary cholesterol excretion). Forced SHP or GATA4 expression rescues respective phenotypes.","method":"Global and liver-specific Bmal1 KO mice on ApoE-/- and Ldlr-/- backgrounds, forced expression of SHP and GATA4, lipoprotein secretion assays, biliary cholesterol measurement, western blot/qPCR","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple KO models plus gain-of-function rescue experiments establishing genetic epistasis, replicated across multiple mouse backgrounds","pmids":["27721414"],"is_preprint":false},{"year":2021,"finding":"BMAL1 directly transactivates the Dgat2 gene (encoding triacylglycerol synthesis enzyme DGAT2) via direct binding to an E-box in the promoter, promoting dietary fat absorption. Intestinal Bmal1 deficiency impairs lipid resynthesis and reduces fat secretion; Rev-erbα deficiency (enhancing BMAL1 activity) exacerbates this.","method":"Intestine-specific Bmal1 KO mice, ChIP assay for E-box binding in Dgat2 promoter, luciferase reporter, lipid absorption assays, Rev-erbα intestinal KO","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP plus reporter plus conditional KO plus epistasis with Rev-erbα, multiple orthogonal methods in single lab","pmids":["34493722"],"is_preprint":false},{"year":2022,"finding":"S6K1 phosphorylates BMAL1 at serine 42, causing its dissociation from the Adipoq promoter. This leads to EZH2 recruitment and H3K27me3 modification of the Adipoq promoter, suppressing adiponectin expression. Fasting inactivates S6K1, triggering an EZH2-to-BMAL1 transcriptional switch that promotes adiponectin expression.","method":"S6K1 kinase assay, ChIP for BMAL1 and EZH2/H3K27me3 at Adipoq promoter, S6K1 KO mice, phospho-Ser42 BMAL1 detection, promoter reporter assays","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — kinase assay identifying phosphorylation site plus ChIP for chromatin state plus in vivo KO, multiple orthogonal methods","pmids":["35338256"],"is_preprint":false},{"year":2023,"finding":"Astrocyte-specific BMAL1 deletion induces Bag3 expression, a chaperone critical for macroautophagy, enhancing astrocyte phagocytosis of alpha-synuclein and tau in a BAG3-dependent manner. Astrocyte Bag3 overexpression is sufficient to mitigate alpha-synuclein spreading in vivo, placing BMAL1 upstream of BAG3-mediated protein clearance.","method":"Astrocyte-specific Bmal1 KO, Bag3 KO rescue experiments, Bag3 overexpression in vivo, phagocytosis assays for alpha-synuclein and tau, tauopathy and alpha-synucleinopathy mouse models","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with conditional KO plus BAG3 gain- and loss-of-function plus in vivo disease models, multiple orthogonal approaches","pmids":["37315555"],"is_preprint":false},{"year":2023,"finding":"BMAL1 deletion in astrocytes influences endolysosomal function, autophagy, and protein degradation dynamics in a cell-autonomous manner. Bmal1-deficient astrocytes exhibit increased endocytosis, lysosome-dependent protein cleavage, and accumulation of LAMP1- and RAB7-positive organelles in vitro; astrocyte-specific Bmal1 KO brains show accumulation of autophagosome-like structures in vivo by electron microscopy. Transcriptional dysregulation of lysosome function pathways occurs independently of TFEB activation.","method":"Astrocyte-specific Bmal1 KO, electron microscopy, LAMP1/RAB7 immunostaining, endocytosis assays, lysosomal protease activity, RNA-seq of isolated astrocytes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with electron microscopy, organelle markers, functional assays, and transcriptomics, multiple orthogonal methods","pmids":["37155839"],"is_preprint":false},{"year":2018,"finding":"BMAL1 cell-autonomously regulates astrocyte activation (astrogliosis) and inflammatory gene expression. Astrocyte-specific Bmal1 deletion induces astrocyte activation in vitro and in vivo, mediated in part by suppression of glutathione-S-transferase signaling. Loss of astrocyte BMAL1 promotes neuronal death in vitro.","method":"Astrocyte-specific Bmal1 KO (in vitro and in vivo), inflammatory gene expression profiling, glutathione-S-transferase pathway analysis, neuronal co-culture death assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with cell-autonomous pathway identification and functional neuronal death readout, multiple orthogonal methods","pmids":["30282019"],"is_preprint":false},{"year":2017,"finding":"BMAL1 expression in skeletal muscle is both necessary and sufficient to regulate total sleep amount. Restoring Bmal1 only in skeletal muscle of Bmal1-KO mice rescued sleep-amount phenotypes; muscle-specific Bmal1 KO reproduced them. Overexpression of skeletal-muscle Bmal1 reduced the recovery response to sleep loss.","method":"Brain-specific and muscle-specific Bmal1 rescue in global KO mice, muscle-specific Bmal1 KO, polysomnographic sleep recording","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific rescue and KO with quantitative sleep phenotyping, multiple genetic approaches establishing necessity and sufficiency","pmids":["28726633"],"is_preprint":false},{"year":2023,"finding":"Bmal1 inhibits axon regeneration of dorsal root ganglia neurons by acting as a gatekeeper of neuroepigenetic responses to axonal injury, limiting Tet3 expression and restricting 5-hydroxymethylcytosine (5hmC) modifications at regeneration-associated genes. Conditional neuronal Bmal1 deletion enhances axon regeneration in vitro and in vivo. Diurnal oscillation of Tet3 and 5hmC in DRG neurons corresponds to time-of-day effect on axon growth potential.","method":"Neuron-specific conditional Bmal1 KO, in vitro and in vivo neurite outgrowth assays, ChIP for 5hmC, RNA-seq, Tet3 expression analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with epigenetic ChIP, transcriptomics, and functional axon growth assays, multiple orthogonal methods","pmids":["37620297"],"is_preprint":false},{"year":2019,"finding":"BMAL1 directly binds the MITF promoter and transcriptionally regulates its expression, which positively influences melanin synthesis. BMAL1 overexpression increases MITF and melanin levels in human melanocytes/melanoma cells and protects against UVB-induced DNA damage.","method":"ChIP for BMAL1 at MITF promoter, luciferase reporter assay, BMAL1 overexpression/knockdown, melanin quantification, UVB treatment","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — ChIP and reporter assay plus functional melanin assay, single lab with multiple orthogonal methods","pmids":["34160901"],"is_preprint":false},{"year":2024,"finding":"BMAL1 directly regulates neuronal survival in dopaminergic (TH+) neurons of the substantia nigra pars compacta in a cell-autonomous manner. Pan-neuronal or TH neuron-specific Bmal1 deletion caused spontaneous TH+ neuron loss. Transcriptomics revealed dysregulation of oxidative phosphorylation and Parkinson disease pathways.","method":"Cell-type-specific Cre-lox Bmal1 KO (pan-neuronal, TH-specific, astrocyte, microglia), stereological TH+ neuron counting, RNA-seq","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple cell-type-specific KO models establishing cell autonomy, with transcriptomic pathway analysis","pmids":["38032732"],"is_preprint":false},{"year":2021,"finding":"BMAL1 transcriptionally regulates Rab27a (a key exosome secretion gene) via luciferase assay, promoting exosome release from colorectal cancer cells and facilitating cancer cell migration.","method":"Luciferase reporter assay for Rab27a promoter, BMAL1 overexpression/knockdown, exosome isolation and quantification, migration assays","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Weak — luciferase assay plus functional exosome and migration readouts, single lab, single method for direct binding","pmids":["34727291"],"is_preprint":false},{"year":2022,"finding":"Polyamines stimulate BMAL1 and REV-ERBα protein synthesis at the translational level through enhancement of ribosomal shunting within the 5'-UTR of their mRNAs. In polyamine-reduced cells, BMAL1 synthesis is reduced and circadian period is lengthened.","method":"EGFP fusion reporter with wild-type or mutated 5'-UTR of Bmal1 mRNA, polyamine depletion experiments, circadian period measurement in NIH3T3 cells","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — 5'-UTR mutational analysis in reporter assay plus polyamine depletion with functional period readout, single lab","pmids":["33525630"],"is_preprint":false},{"year":2019,"finding":"BMAL1 (ARNTL) associates with telomere DNA in a rhythmic/diurnal fashion in zebrafish and mice, and controls a circadian rhythm in TERRA (Telomeric Repeat-containing RNA). BMAL1-dependent H3K9me3 rhythm at telomeres is lost in aged animals, linking BMAL1 to telomere heterochromatin maintenance.","method":"ChIP for BMAL1 at telomere DNA, TERRA RT-qPCR in Bmal1-/- mouse liver, H3K9me3 ChIP at telomeres in zebrafish and mice, aging comparison","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct telomere binding plus KO validation plus aging comparison, single lab with multiple methods","pmids":["31634367"],"is_preprint":false},{"year":2021,"finding":"BMAL1 dephosphorylation by protein phosphatase 4 (PPP4) participates in modulating circadian timing and determines the pace of the circadian clock (as reviewed based on findings by Klemz et al.).","method":"Biochemical/genetic analysis of PPP4-mediated BMAL1 dephosphorylation (referenced in review/perspective based on original research)","journal":"Genes & development","confidence":"Low","confidence_rationale":"Tier 3 / Weak — perspective/commentary article describing findings from another study; original experimental details not provided in this abstract","pmids":["34341001"],"is_preprint":false},{"year":2025,"finding":"A small molecule (CCM) targeting the PASB domain cavity of BMAL1 causes expansion of the cavity, conformational changes in the PASB domain, and alters BMAL1 function as a transcription factor. CCM induces dose-dependent alterations in PER2-Luc oscillations and downregulates inflammatory and phagocytic pathways in macrophages. Crystal/structural and biochemical studies validate selectivity.","method":"Small molecule design, structural studies (BMAL1 PASB domain), biochemical binding assays, PER2-Luc reporter assay, macrophage inflammatory assays","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural plus biochemical plus cellular validation, multiple orthogonal methods identifying ligand-binding cavity in BMAL1 PASB domain","pmids":["40133642"],"is_preprint":false},{"year":2020,"finding":"BMAL1 directly interacts with NF-κB p65 (RelA) subunit in theca cells and negatively regulates PI3K/NF-κB signaling, thereby controlling steroidogenesis-associated gene expression including Lhcgr, Hsd3β2, and Cyp17a1.","method":"Co-IP for BMAL1-RelA interaction, PI3K inhibitor rescue, siRNA-mediated Bmal1 knockdown in granulosa and theca cells, Bmal1 KO mice, hormone measurement","journal":"Reproduction","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP establishing direct interaction plus pharmacological and genetic rescue, single lab","pmids":["33112769"],"is_preprint":false},{"year":2019,"finding":"BMAL1 (ARNTL) acts as a transcription factor that suppresses NPC cell proliferation and enhances cisplatin sensitivity by directly binding the CDK5 promoter and activating CDK5 transcription, as validated by dual luciferase reporter and ChIP assays. CDK5 overexpression reverses the suppressive effects of BMAL1.","method":"Dual luciferase reporter assay for CDK5 promoter, ChIP assay, ARNTL overexpression and CDK5 overexpression epistasis experiment, proliferation and cisplatin sensitivity assays","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — luciferase and ChIP plus epistasis rescue, single lab with multiple orthogonal methods","pmids":["30621723"],"is_preprint":false},{"year":2022,"finding":"BMAL1 promotes OPC (oligodendrocyte precursor cell) proliferation in a time-of-day-dependent manner. OPC-specific Bmal1 KO disrupts circadian gene expression, proliferation, density, morphology, and migration, leading to thinner myelin and sleep fragmentation. In adults, OPC-specific Bmal1 loss impairs remyelination via changes in OPC morphology and migration.","method":"OPC-specific Bmal1 KO during development and adulthood, RNA-seq, immunostaining, electron microscopy for myelin thickness, demyelination lesion model, sleep recording","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO in two temporal windows with multiple cellular, molecular, and functional readouts, single lab","pmids":["37657440"],"is_preprint":false},{"year":2023,"finding":"BMAL1 binds the promoters of CCNA1 and CDK1 genes in endothelial cells (by ChIP-seq) and controls their expression, thereby regulating EC cell cycle progression. EC-specific BMAL1 impairment causes angiogenesis defects in neonatal vascular tissues and adult tumor angiogenesis settings.","method":"EC-specific Bmal1 KO in vivo, BMAL1 ChIP-seq in ECs, cell cycle analysis, angiogenesis assays (neonatal retina and tumor), RNA-seq","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-seq identifying direct target gene binding plus conditional KO with in vivo angiogenesis readouts, multiple orthogonal methods","pmids":["37052172"],"is_preprint":false},{"year":2024,"finding":"Hepatic BMAL1 and HIF1α cooperate in the circadian response to hypoxia through shared and distinct regulatory roles. HIF1α accumulation upon hypoxia is temporally regulated and Bmal1-dependent. Loss of both hepatic Bmal1 and Hif1α causes hypoxemia, pulmonary vasodilation (via ERK-eNOS-NO), and mortality in a daytime-dependent manner, resembling hepatopulmonary syndrome.","method":"Liver-specific Bmal1 KO, liver-specific Hif1α KO, double KO, hypoxia exposure at different times of day, transcriptomics, eNOS/NO measurement, ERK activation assays","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple conditional KOs with mechanistic pathway analysis (ERK-eNOS-NO) and time-dependent mortality readout, multiple orthogonal methods","pmids":["39106859"],"is_preprint":false},{"year":2018,"finding":"LIN28A directly binds the BMAL1 promoter under H. pylori infection and activates BMAL1 transcription. In turn, BMAL1 functions as a transcription factor to enhance expression of proinflammatory TNF-α, promoting gastric inflammation.","method":"ChIP assay for LIN28A at BMAL1 promoter, dual luciferase reporter assay, H. pylori infection models in vitro and in vivo","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay establishing LIN28A-BMAL1-TNF-α axis, single lab with two orthogonal methods","pmids":["30502053"],"is_preprint":false},{"year":2022,"finding":"BMAL1 non-canonically sequesters myosin heavy chain 9 (MYH9) to increase MRTF-SRF activity and AP-1 transcriptional signature, shifting melanoma cells from a Sox10-high to Sox9-high mesenchymal/immune-resistant cell state. This occurs independently of BMAL1's transcriptional activity, as a transcriptionally inactive BMAL1 mutant retains this function.","method":"Co-IP for BMAL1-MYH9 interaction, BMAL1 transcriptionally inactive mutant expression, MRTF-SRF reporter assays, scRNA-seq cell state analysis, tumor growth assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus transcriptionally inactive mutant establishing non-canonical function, single lab with multiple orthogonal methods","pmids":["38245503"],"is_preprint":false},{"year":2022,"finding":"BMAL1 in cerebellar Purkinje cells (PCs) is required cell-autonomously for normal synaptic transmission and dendritic spine maturation. Bmal1 KO in PCs causes enhanced excitatory and inhibitory synaptic transmission, reduced PC firing, aberrant spine density/morphology, hyperactivated mTORC1 signaling, and autistic-like behaviors. Metformin reversal of mTORC1 hyperactivation rescues behavioral and cellular deficits.","method":"Global and PC-specific Bmal1 KO, electrophysiology, dendritic spine morphology, mTORC1 activity assays, metformin rescue, behavioral tests","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with electrophysiology, spine morphology, and pharmacological rescue, multiple orthogonal methods","pmids":["35301425"],"is_preprint":false},{"year":2025,"finding":"In skeletal muscle during diet-induced obesity, BMAL1 regulates HIF-driven glycolysis and metabolic flexibility. Muscle-specific BMAL1 deficiency impairs early glycolytic steps and worsens glucose tolerance. Genetic HIF1α stabilization in muscle Bmal1-deficient mice restores glucose tolerance and rescues 217/736 dysregulated genes, establishing BMAL1 upstream of HIF1α in muscle glucose metabolism.","method":"Muscle-specific Bmal1 KO, metabolite profiling, glucose tolerance tests, HIF1α genetic stabilization rescue, RNA-seq in high-fat diet conditions","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with metabolomics plus genetic HIF1α rescue establishing epistasis, multiple orthogonal methods","pmids":["40127275"],"is_preprint":false},{"year":2019,"finding":"BMAL1 directly activates Ptch1 and Ihh promoters (binding to their promoter regions), regulating hedgehog signaling in mandibular condylar chondrocytes. BMAL1 deficiency impairs sequential chondrocyte differentiation and endochondral ossification; hedgehog signaling activator rescues the short stature phenotype.","method":"ChIP for BMAL1 at Ptch1 and Ihh promoters, RNA-seq in Bmal1-/- mandibular condyle, hedgehog activator rescue of BMAL1-deficient phenotype, micro-CT and histology","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct promoter binding plus genetic rescue, single lab","pmids":["31747713"],"is_preprint":false},{"year":2022,"finding":"PPAR-γ trans-activates Slc1a5 via a response element in its promoter, driving glutamine/methionine uptake in adipocytes. Impaired PPAR-γ in obesity reduces SLC1A5 and glutamine/methionine, decreasing H3K27ac and H3K4me3 at the Bmal1 promoter and disrupting Bmal1 transcription.","method":"ChIP assay for H3K27ac and H3K4me3 at Bmal1 promoter, luciferase reporter for PPAR-γ/SLC1A5 axis, in vitro and in vivo glutamine/methionine supplementation, qPCR/western blot","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter plus metabolic rescue experiments, single lab with multiple orthogonal methods","pmids":["35198059"],"is_preprint":false},{"year":2013,"finding":"DNA methylation of the BMAL1 promoter CpG islands silences circadian BMAL1 expression. Treatment with the demethylating agent 5-aza-2'-deoxycytidine recovers BMAL1 expression and circadian oscillation. Reporter gene assays confirm that transcriptional machinery for BMAL1 is active, and methylation (not promoter dysfunction) is the cause of silencing.","method":"Bisulfite sequencing of BMAL1 promoter CpG islands, 5-aza-dC treatment, luciferase reporter assay, qPCR for circadian oscillation recovery","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bisulfite sequencing plus reporter assay plus pharmacological demethylation rescue, single lab","pmids":["24103761"],"is_preprint":false},{"year":2020,"finding":"BMAL1 promotes mitophagy via SIRT1 to alleviate myocardial injury in sepsis. BMAL1 knockdown inhibits SIRT1 and mitophagy-associated proteins; SIRT1 overexpression partially reverses effects of BMAL1 knockdown, placing BMAL1 upstream of SIRT1 in a pro-mitophagy pathway in cardiomyocytes.","method":"siRNA/shRNA Bmal1 knockdown and overexpression in H9C2 cells, SIRT1 overexpression rescue, mitophagy protein expression (western blot), apoptosis/ROS by flow cytometry, cecal ligation-puncture in vivo model","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — genetic epistasis (SIRT1 rescue of Bmal1 KD) plus in vivo model, single lab","pmids":["38678672"],"is_preprint":false},{"year":2024,"finding":"BMAL1 overexpression reduces YAP transcriptional activity and inhibits the Hippo signaling pathway in renal tubular epithelial cells; ChIP-qPCR identifies YAP as a direct BMAL1 target. YAP positively regulates ACSL4, promoting ferroptosis. Inhibiting YAP (by Verteporfin) reverses BMAL1-downregulation-induced ferroptosis.","method":"BMAL1 overexpression, ChIP-qPCR for BMAL1 at YAP promoter, Verteporfin rescue, ferroptosis markers, transcriptome sequencing, in vivo sepsis-AKI model","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-qPCR plus epistasis rescue plus in vivo model, single lab","pmids":["39303541"],"is_preprint":false},{"year":2021,"finding":"BMAL1 (ARNTL) in EPIYA L-cells is required for rhythmic GLP-1 secretion; L-cell-specific Arntl KO reduces GLP-1 secretion at peak time points and impairs time-dependent GLP-1 release. L-cell Arntl disruption also alters intestinal CD4+ intraepithelial lymphocytes, proinflammatory cytokine expression, and colonic microbiome composition.","method":"Inducible L-cell-specific Arntl KO mice, oral glucose tolerance tests at ZT2 and ZT14, GLP-1 measurement, siRNA knockdown in mGLUTag cells, transcriptomic analysis, microbiome 16S rRNA sequencing","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO plus in vitro siRNA with functional secretion readout, single lab with multiple orthogonal methods","pmids":["34520858"],"is_preprint":false},{"year":2022,"finding":"Circadian rhythm disruption (by melatonin receptor 1/AMPKβ1 pathway perturbation) impairs endochondral bone formation. Mechanistically, melatonin receptor 1 (MTR1) periodically activates AMPKβ1 phosphorylation, which destabilizes CRY1 and triggers BMAL1 expression, coordinating circadian rhythms of chondrocyte proliferation and matrix synthesis.","method":"Circadian disruption mouse models, AMPKβ1 agonist rescue, AMPKβ1 phosphorylation assays, CRY1 stability assays, BMAL1 expression analysis, bone formation histology","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection (AMPKβ1 agonist rescue) plus stability assays, single lab","pmids":["35094018"],"is_preprint":false},{"year":2024,"finding":"Circadian disruption causes BMAL1 to suppress MUC4 expression in corneal epithelial cells, contributing to dry eye pathology. BMAL1 silencing reduces MUC4 expression and BMAL1 overexpression increases it in cultured human corneal epithelial cells in vitro. Genetic BMAL1 ablation in mice recapitulates MUC4 deficiency and dry eye disease.","method":"BMAL1 siRNA and overexpression in human corneal epithelial cells, Bmal1 KO mice, MUC4 protein/mRNA measurement, corneal surface assessment","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — in vitro gain/loss-of-function plus in vivo KO with functional readout, single lab","pmids":["38956298"],"is_preprint":false}],"current_model":"BMAL1 is the obligate positive-arm transcription factor of the mammalian circadian clock that heterodimerizes with CLOCK (and non-canonically with HIF2A) to bind E-box elements as a pioneer-like factor, driving rhythmic gene expression across virtually all tissues; its activity and stability are regulated by post-translational modifications including GSK3β-mediated phosphorylation (Ser17/Thr21) triggering ubiquitin-proteasome degradation, S6K1-mediated phosphorylation (Ser42) causing promoter dissociation, synaptic phosphorylation (Ser42) gating hippocampal LTP, and PPP4-mediated dephosphorylation setting clock pace, while protein stability is further maintained by the necdin-SGT1-HSP90 chaperone machinery; beyond transcriptional roles, BMAL1 non-canonically stabilizes heterochromatin at LINE1 loci to suppress retrotransposon activation and sequesters MYH9 to modulate MRTF-SRF cytoskeletal signaling, and cell-type-specific functions include regulating macrophage mitochondrial metabolism and RhoA-dependent phagocytosis, astrocyte BAG3-mediated protein clearance and lysosomal function, skeletal muscle sleep regulation, OPC myelination, dopaminergic neuron survival, and hepatic lipid/drug metabolism through direct transcriptional control of targets including DGAT2, Cyp3a11, MRP2, SULT1A1, MITF, CDK1, and CCNA1."},"narrative":{"mechanistic_narrative":"BMAL1 is the obligate positive-arm transcription factor of the mammalian circadian clock, functioning as a pioneer-like factor that binds nucleosomes, promotes rhythmic chromatin opening with H2A.Z incorporation, and enables time-of-day binding of other transcription factors to generate genome-wide rhythmic output [PMID:24395244]. Its rhythmic transcription is itself sustained by a REV-ERB/ROR (RRE) element feedback loop that confers resistance to perturbation of the core E-box oscillation [PMID:35999195], while promoter CpG methylation can silence BMAL1 expression entirely [PMID:24103761]. BMAL1 activity and abundance are tightly tuned by post-translational control: GSK3β phosphorylates Ser17/Thr21 to prime ubiquitin-proteasomal degradation downstream of dopamine D2 receptor signaling [PMID:20049328], S6K1 phosphorylation of Ser42 drives promoter dissociation and an EZH2-dependent repressive chromatin switch [PMID:35338256], synaptic Ser42 phosphorylation gates CaMKIIα-dependent hippocampal LTP [PMID:37878694], and BMAL1 protein is stabilized by a necdin–SGT1–HSP90 chaperone module [PMID:32667666]. As a transcription factor BMAL1 directly drives diverse tissue programs, activating metabolic and drug-handling targets including Dgat2, Cyp3a11, Sult1a1, and an intestinal Dbp/Rev-erbα→Mrp2 cascade [PMID:34493722, PMID:31633069, PMID:30064996, PMID:31244920], and controlling cell-cycle, survival, and differentiation genes such as CDK1/CCNA1 in endothelial cells, MITF in melanocytes, and hedgehog effectors Ptch1/Ihh in chondrocytes [PMID:37052172, PMID:34160901, PMID:31747713]. Beyond canonical CLOCK partnership, BMAL1 forms a non-canonical, diurnally regulated heterodimer with HIF2A—whose structure was resolved by cryo-EM—to stabilize HIF2A and drive the rhythmic hypoxic target AREG [PMID:40269168], and it acts upstream of HIF1α in hepatic and skeletal-muscle hypoxia and glucose-metabolism programs [PMID:39106859, PMID:40127275]. BMAL1 also performs transcription-independent functions: it stabilizes heterochromatin at LINE1 loci to suppress the cGAS-STING pathway during aging [PMID:35286396] and sequesters MYH9 to modulate MRTF-SRF cytoskeletal signaling and melanoma cell state [PMID:38245503]. These activities underlie cell-type-specific roles spanning macrophage mitochondrial metabolism and RhoA-dependent phagocytosis [PMID:32396064, PMID:31900362], astrocyte BAG3-mediated protein clearance and endolysosomal function [PMID:37315555, PMID:37155839], skeletal-muscle control of sleep amount [PMID:28726633], oligodendrocyte precursor proliferation and myelination [PMID:37657440], and dopaminergic neuron survival [PMID:38032732].","teleology":[{"year":2010,"claim":"Established that BMAL1 abundance is controlled by signal-driven phosphodegradation, linking neurotransmitter signaling to clock amplitude.","evidence":"In vitro kinase and ubiquitylation assays with Ser17/Thr21 mutagenesis and D2 receptor pharmacology in striatal neurons","pmids":["20049328"],"confidence":"High","gaps":["E3 ligase mediating the ubiquitylation not defined here","in vivo phosphorylation stoichiometry over the circadian cycle not measured"]},{"year":2014,"claim":"Defined how a single heterodimer generates heterogeneous genome-wide rhythms: CLOCK:BMAL1 acts as a pioneer-like factor remodeling chromatin to license other factors.","evidence":"Genome-wide ChIP-seq, ATAC-seq, and histone variant (H2A.Z) profiling","pmids":["24395244"],"confidence":"High","gaps":["chromatin remodelers recruited by BMAL1 not identified","which secondary factors are licensed at each locus left open"]},{"year":2016,"claim":"Connected hepatic BMAL1 to systemic lipid and cholesterol handling through defined intermediary transcription factors.","evidence":"Global and liver-specific Bmal1 KO on ApoE-/- and Ldlr-/- backgrounds with SHP/GATA4 gain-of-function rescue","pmids":["27721414"],"confidence":"High","gaps":["direct vs indirect regulation of Shp/Gata4 not fully resolved","human relevance not tested"]},{"year":2018,"claim":"Showed BMAL1 transcriptional output is gated by tissue-specific repressors and reciprocal feedback in liver and colon oscillators.","evidence":"Reciprocal luciferase assays, genome-wide HNF4A/CLOCK:BMAL1 co-occupancy ChIP-seq, and HNF4A knockdown","pmids":["30530698"],"confidence":"High","gaps":["mechanism of HNF4A transrepression at chromatin not defined","generalizability beyond liver/colon untested"]},{"year":2018,"claim":"Demonstrated that direct BMAL1 transcriptional targets extend to xenobiotic-handling enzymes, establishing a clock basis for drug pharmacokinetics.","evidence":"EMSA, ChIP, and luciferase reporters at the Sult1a1 E-box in Bmal1-deficient mice and serum-shocked cells","pmids":["30064996"],"confidence":"Medium","gaps":["single-site analysis; broader enzyme network not mapped","human SULT1A1 regulation not addressed"]},{"year":2019,"claim":"Mapped a multi-tier BMAL1 transcriptional cascade controlling intestinal drug transport and CYP enzyme rhythms.","evidence":"Intestine-specific Bmal1 KO with EMSA/ChIP/reporter and in vivo pharmacokinetics for Mrp2 and Cyp3a11","pmids":["31244920","31633069"],"confidence":"High","gaps":["relative contribution of each intermediary (Dbp, Rev-erba, Hnf4a) in vivo not quantified"]},{"year":2020,"claim":"Identified a chaperone machinery that maintains BMAL1 protein stability, defining a post-translational input to clock pace independent of transcription.","evidence":"Yeast two-hybrid, Co-IP with domain mapping, HSP90/proteasome inhibitor rescue, and necdin-KO mouse phenotyping","pmids":["32667666"],"confidence":"High","gaps":["how chaperone availability is itself regulated rhythmically not addressed"]},{"year":2020,"claim":"Revealed BMAL1 as a metabolic and cytoskeletal regulator in macrophages, linking the clock to mitochondrial function, HIF-1α reprogramming, and RhoA-dependent phagocytosis.","evidence":"Myeloid-specific Bmal1 KO with metabolic readouts, phosphoproteomics, RhoA activity assays, ChIP-seq, and pharmacological rescue","pmids":["32396064","31900362"],"confidence":"High","gaps":["whether cytoskeletal control is transcriptional or post-translational in macrophages not fully separated"]},{"year":2022,"claim":"Established a transcription-independent genome-protective role for BMAL1 in heterochromatin maintenance at LINE1 elements during aging.","evidence":"BMAL1 loss-of-function in primate MPCs with chromatin fractionation, LINE1 ChIP, and cGAS-STING pathway assays","pmids":["35286396"],"confidence":"High","gaps":["how BMAL1 is recruited to LINE1 heterochromatin not defined","relationship to its E-box DNA binding unresolved"]},{"year":2022,"claim":"Showed that rhythmic Bmal1 transcription via RRE elements buffers the clock against perturbation, defining the functional purpose of the auxiliary feedback loop.","evidence":"CRISPR deletion of RRE elements in cells and mice with mathematical modeling and CRY1 manipulation","pmids":["35999195"],"confidence":"High","gaps":["molecular nature of the perturbation buffering not mechanistically dissected"]},{"year":2022,"claim":"Defined an S6K1-Ser42 phosphorylation switch that couples nutrient/fasting signaling to a BMAL1→EZH2 chromatin state change at metabolic gene promoters.","evidence":"S6K1 kinase assay, phospho-Ser42 detection, ChIP for BMAL1/EZH2/H3K27me3 at Adipoq, and S6K1 KO mice","pmids":["35338256"],"confidence":"High","gaps":["whether the EZH2 switch operates at other BMAL1 targets genome-wide untested"]},{"year":2023,"claim":"Connected BMAL1 to neuronal physiology through synaptic localization and cell-autonomous roles in protein clearance, axon regeneration, and synaptic maturation.","evidence":"Astrocyte-, neuron-, and Purkinje-cell-specific Bmal1 KO with synaptic fractionation, electrophysiology, BAG3/lysosomal assays, and 5hmC ChIP","pmids":["37878694","37315555","37155839","37620297","35301425"],"confidence":"High","gaps":["extent to which these roles are circadian vs constitutive not always separated","direct BMAL1 target genes in each neural context only partially mapped"]},{"year":2024,"claim":"Positioned BMAL1 upstream of HIF1α in tissue hypoxia and glucose-metabolism programs through epistatic rescue.","evidence":"Liver and skeletal-muscle conditional Bmal1 KO with genetic HIF1α stabilization rescue, metabolomics, and time-dependent physiology","pmids":["39106859","40127275"],"confidence":"High","gaps":["molecular mechanism by which BMAL1 restrains HIF1α accumulation not defined"]},{"year":2025,"claim":"Resolved a non-canonical BMAL1-HIF2A heterodimer structurally and functionally, demonstrating direct circadian-hypoxia transcriptional cross-talk.","evidence":"Cryo-EM of the BMAL1-HIF2A-DNA complex with Co-IP, HIF2A stability assays, ChIP, and cardiac ischemia models","pmids":["40269168"],"confidence":"High","gaps":["genome-wide scope of BMAL1-HIF2A targets beyond AREG not mapped","competition with CLOCK for BMAL1 not quantified"]},{"year":2025,"claim":"Demonstrated that a small molecule binding the BMAL1 PASB cavity can allosterically reshape its transcription factor activity, validating BMAL1 as a directly druggable target.","evidence":"Small-molecule design with structural and biochemical binding studies, PER2-Luc oscillation readouts, and macrophage assays","pmids":["40133642"],"confidence":"High","gaps":["selectivity over related PAS-domain proteins in vivo not fully established","therapeutic window unaddressed"]},{"year":null,"claim":"How BMAL1 partitions between its canonical CLOCK-dependent transcriptional role and its transcription-independent functions (heterochromatin stabilization, MYH9 sequestration, HIF partnerships) within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["no quantitative model of how BMAL1 pools are allocated among functions","recruitment mechanisms to non-E-box sites undefined","in vivo consequences of decoupling transcriptional from non-transcriptional roles untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,13,14,15,18,25,33,35,41]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,5,29]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[38]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,3,19]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[5,29]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-9909396","term_label":"Circadian clock","supporting_discovery_ids":[1,12,30]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,13,14,18,35]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,5,19]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[17,18,40]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3,36,40]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,7]}],"complexes":["CLOCK:BMAL1 heterodimer","BMAL1-HIF2A heterodimer"],"partners":["CLOCK","HIF2A","HNF4A","MYH9","NDN","SGT1","RELA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00327","full_name":"Basic helix-loop-helix ARNT-like protein 1","aliases":["Aryl hydrocarbon receptor nuclear translocator-like protein 1","Basic-helix-loop-helix-PAS protein MOP3","Brain and muscle ARNT-like 1","Class E basic helix-loop-helix protein 5","bHLHe5","Member of PAS protein 3","PAS domain-containing protein 3","bHLH-PAS protein JAP3"],"length_aa":626,"mass_kda":68.8,"function":"Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. BMAL1 positively regulates myogenesis and negatively regulates adipogenesis via the transcriptional control of the genes of the canonical Wnt signaling pathway. Plays a role in normal pancreatic beta-cell function; regulates glucose-stimulated insulin secretion via the regulation of antioxidant genes NFE2L2/NRF2 and its targets SESN2, PRDX3, CCLC and CCLM. Negatively regulates the mTORC1 signaling pathway; regulates the expression of MTOR and DEPTOR. Controls diurnal oscillations of Ly6C inflammatory monocytes; rhythmic recruitment of the PRC2 complex imparts diurnal variation to chemokine expression that is necessary to sustain Ly6C monocyte rhythms. Regulates the expression of HSD3B2, STAR, PTGS2, CYP11A1, CYP19A1 and LHCGR in the ovary and also the genes involved in hair growth. Plays an important role in adult hippocampal neurogenesis by regulating the timely entry of neural stem/progenitor cells (NSPCs) into the cell cycle and the number of cell divisions that take place prior to cell-cycle exit. Regulates the circadian expression of CIART and KLF11. The CLOCK-BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The NPAS2-BMAL1 heterodimer positively regulates the expression of MAOA, F7 and LDHA and modulates the circadian rhythm of daytime contrast sensitivity by regulating the rhythmic expression of adenylate cyclase type 1 (ADCY1) in the retina. The preferred binding motif for the CLOCK-BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking adenine nucleotide at the 3-prime end of the canonical 6-nucleotide E-box sequence (PubMed:23229515). CLOCK specifically binds to the half-site 5'-CAC-3', while BMAL1 binds to the half-site 5'-GTGA-3' (PubMed:23229515). The CLOCK-BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3' (PubMed:23229515). Essential for the rhythmic interaction of CLOCK with ASS1 and plays a critical role in positively regulating CLOCK-mediated acetylation of ASS1 (PubMed:28985504). Plays a role in protecting against lethal sepsis by limiting the expression of immune checkpoint protein CD274 in macrophages in a PKM2-dependent manner (By similarity). Regulates the diurnal rhythms of skeletal muscle metabolism via transcriptional activation of genes promoting triglyceride synthesis (DGAT2) and metabolic efficiency (COQ10B) (By similarity) (Microbial infection) Regulates SARS coronavirus-2/SARS-CoV-2 entry and replication in lung epithelial cells probably through the post-transcriptional regulation of ACE2 and interferon-stimulated gene expression","subcellular_location":"Nucleus; Cytoplasm; Nucleus, PML body","url":"https://www.uniprot.org/uniprotkb/O00327/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BMAL1","classification":"Not Classified","n_dependent_lines":25,"n_total_lines":1208,"dependency_fraction":0.020695364238410598},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BMAL1","total_profiled":1310},"omim":[{"mim_id":"619771","title":"VRK SERINE/THREONINE KINASE 3; VRK3","url":"https://www.omim.org/entry/619771"},{"mim_id":"616995","title":"CLOCK-INTERACTING PACEMAKER; CIPC","url":"https://www.omim.org/entry/616995"},{"mim_id":"616798","title":"ZINC FINGER PROTEIN 28; ZFP28","url":"https://www.omim.org/entry/616798"},{"mim_id":"615782","title":"CIRCADIAN-ASSOCIATED REPRESSOR OF TRANSCRIPTION; CIART","url":"https://www.omim.org/entry/615782"},{"mim_id":"614517","title":"BRAIN AND MUSCLE ARNT-LIKE PROTEIN 2; BMAL2","url":"https://www.omim.org/entry/614517"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BMAL1"},"hgnc":{"alias_symbol":["MOP3","JAP3","PASD3","bHLHe5","ARNTL1"],"prev_symbol":["ARNTL"]},"alphafold":{"accession":"O00327","domains":[{"cath_id":"4.10.280.10","chopping":"61-125","consensus_level":"high","plddt":84.1803,"start":61,"end":125},{"cath_id":"3.30.450.20","chopping":"138-213_236-255_276-292_310-321","consensus_level":"medium","plddt":85.5533,"start":138,"end":321},{"cath_id":"3.30.450.20","chopping":"338-443_489-506","consensus_level":"high","plddt":93.5088,"start":338,"end":506}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00327","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00327-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00327-F1-predicted_aligned_error_v6.png","plddt_mean":65.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BMAL1","jax_strain_url":"https://www.jax.org/strain/search?query=BMAL1"},"sequence":{"accession":"O00327","fasta_url":"https://rest.uniprot.org/uniprotkb/O00327.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00327/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00327"}},"corpus_meta":[{"pmid":"20049328","id":"PMC_20049328","title":"Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20049328","citation_count":242,"is_preprint":false},{"pmid":"24395244","id":"PMC_24395244","title":"CLOCK:BMAL1 is a pioneer-like transcription factor.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24395244","citation_count":206,"is_preprint":false},{"pmid":"32078488","id":"PMC_32078488","title":"BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress.","date":"2020","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/32078488","citation_count":196,"is_preprint":false},{"pmid":"24481314","id":"PMC_24481314","title":"BMAL1-dependent regulation of the mTOR signaling pathway delays aging.","date":"2014","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/24481314","citation_count":176,"is_preprint":false},{"pmid":"26657859","id":"PMC_26657859","title":"The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26657859","citation_count":173,"is_preprint":false},{"pmid":"32396064","id":"PMC_32396064","title":"Bmal1 integrates mitochondrial metabolism and macrophage activation.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32396064","citation_count":137,"is_preprint":false},{"pmid":"30282019","id":"PMC_30282019","title":"Cell-Autonomous Regulation of Astrocyte Activation by the Circadian Clock Protein BMAL1.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30282019","citation_count":137,"is_preprint":false},{"pmid":"28726633","id":"PMC_28726633","title":"Bmal1 function in skeletal muscle regulates sleep.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28726633","citation_count":123,"is_preprint":false},{"pmid":"31900362","id":"PMC_31900362","title":"The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumonia.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31900362","citation_count":116,"is_preprint":false},{"pmid":"27721414","id":"PMC_27721414","title":"Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27721414","citation_count":104,"is_preprint":false},{"pmid":"30341289","id":"PMC_30341289","title":"Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30341289","citation_count":95,"is_preprint":false},{"pmid":"35198059","id":"PMC_35198059","title":"PPAR-γ integrates obesity and adipocyte clock through epigenetic regulation of Bmal1.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35198059","citation_count":93,"is_preprint":false},{"pmid":"20368993","id":"PMC_20368993","title":"ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20368993","citation_count":85,"is_preprint":false},{"pmid":"37315555","id":"PMC_37315555","title":"An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology.","date":"2023","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/37315555","citation_count":82,"is_preprint":false},{"pmid":"35286396","id":"PMC_35286396","title":"BMAL1 moonlighting as a gatekeeper for LINE1 repression and cellular senescence in primates.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35286396","citation_count":80,"is_preprint":false},{"pmid":"24189141","id":"PMC_24189141","title":"Impaired glucocorticoid production and response to stress in Arntl-deficient male mice.","date":"2013","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24189141","citation_count":77,"is_preprint":false},{"pmid":"27884645","id":"PMC_27884645","title":"Dysregulated circadian rhythm pathway in human osteoarthritis: NR1D1 and BMAL1 suppression alters TGF-β signaling in chondrocytes.","date":"2016","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/27884645","citation_count":73,"is_preprint":false},{"pmid":"34493722","id":"PMC_34493722","title":"Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34493722","citation_count":72,"is_preprint":false},{"pmid":"27927724","id":"PMC_27927724","title":"Myeloid Bmal1 deletion increases monocyte recruitment and worsens atherosclerosis.","date":"2016","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27927724","citation_count":71,"is_preprint":false},{"pmid":"30530698","id":"PMC_30530698","title":"Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30530698","citation_count":70,"is_preprint":false},{"pmid":"35999195","id":"PMC_35999195","title":"Rhythmic transcription of Bmal1 stabilizes the circadian timekeeping system in mammals.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35999195","citation_count":69,"is_preprint":false},{"pmid":"31244920","id":"PMC_31244920","title":"The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31244920","citation_count":66,"is_preprint":false},{"pmid":"33363534","id":"PMC_33363534","title":"Deficiency of the Circadian Clock Gene Bmal1 Reduces Microglial Immunometabolism.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33363534","citation_count":64,"is_preprint":false},{"pmid":"31633069","id":"PMC_31633069","title":"Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice.","date":"2019","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/31633069","citation_count":62,"is_preprint":false},{"pmid":"28470120","id":"PMC_28470120","title":"Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.","date":"2017","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/28470120","citation_count":62,"is_preprint":false},{"pmid":"29518061","id":"PMC_29518061","title":"Potential Roles of Dec and Bmal1 Genes in Interconnecting Circadian Clock and Energy Metabolism.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29518061","citation_count":60,"is_preprint":false},{"pmid":"25175925","id":"PMC_25175925","title":"Epigenetic silencing of ARNTL, a circadian gene and potential tumor suppressor in ovarian cancer.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25175925","citation_count":55,"is_preprint":false},{"pmid":"30375470","id":"PMC_30375470","title":"Opposite Carcinogenic Effects of Circadian Clock Gene BMAL1.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30375470","citation_count":54,"is_preprint":false},{"pmid":"37155839","id":"PMC_37155839","title":"Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37155839","citation_count":52,"is_preprint":false},{"pmid":"31300350","id":"PMC_31300350","title":"Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A.","date":"2019","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/31300350","citation_count":52,"is_preprint":false},{"pmid":"35733785","id":"PMC_35733785","title":"Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35733785","citation_count":49,"is_preprint":false},{"pmid":"32251631","id":"PMC_32251631","title":"The biological function of BMAL1 in skeleton development and disorders.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32251631","citation_count":47,"is_preprint":false},{"pmid":"35301425","id":"PMC_35301425","title":"Autistic-like behavior and cerebellar dysfunction in Bmal1 mutant mice ameliorated by mTORC1 inhibition.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/35301425","citation_count":46,"is_preprint":false},{"pmid":"31249486","id":"PMC_31249486","title":"Effects of BMAL1 Manipulation on the Brain's Master Circadian Clock and Behavior.","date":"2019","source":"The Yale journal of biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31249486","citation_count":45,"is_preprint":false},{"pmid":"26134245","id":"PMC_26134245","title":"Association of CLOCK, ARNTL, and NPAS2 gene polymorphisms and seasonal variations in mood and behavior.","date":"2015","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/26134245","citation_count":43,"is_preprint":false},{"pmid":"28432873","id":"PMC_28432873","title":"Conditional Deletion of Bmal1 Accentuates Microvascular and Macrovascular Injury.","date":"2017","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28432873","citation_count":42,"is_preprint":false},{"pmid":"35094018","id":"PMC_35094018","title":"Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35094018","citation_count":40,"is_preprint":false},{"pmid":"40269168","id":"PMC_40269168","title":"BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40269168","citation_count":39,"is_preprint":false},{"pmid":"30621723","id":"PMC_30621723","title":"ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30621723","citation_count":39,"is_preprint":false},{"pmid":"37657440","id":"PMC_37657440","title":"BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep.","date":"2023","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/37657440","citation_count":38,"is_preprint":false},{"pmid":"37052172","id":"PMC_37052172","title":"The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis.","date":"2023","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/37052172","citation_count":36,"is_preprint":false},{"pmid":"23449886","id":"PMC_23449886","title":"Common genetic variants in ARNTL and NPAS2 and at chromosome 12p13 are associated with objectively measured sleep traits in the elderly.","date":"2013","source":"Sleep","url":"https://pubmed.ncbi.nlm.nih.gov/23449886","citation_count":36,"is_preprint":false},{"pmid":"30287810","id":"PMC_30287810","title":"CLOCK and BMAL1 stabilize and activate RHOA to promote F-actin formation in cancer cells.","date":"2018","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30287810","citation_count":35,"is_preprint":false},{"pmid":"31311301","id":"PMC_31311301","title":"Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31311301","citation_count":33,"is_preprint":false},{"pmid":"32667666","id":"PMC_32667666","title":"Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32667666","citation_count":33,"is_preprint":false},{"pmid":"38241675","id":"PMC_38241675","title":"Circadian misalignment impairs oligodendrocyte myelination via Bmal1 overexpression leading to anxiety and depression-like behaviors.","date":"2024","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/38241675","citation_count":31,"is_preprint":false},{"pmid":"28052921","id":"PMC_28052921","title":"The Circadian Oscillator of the Cerebral Cortex: Molecular, Biochemical and Behavioral Effects of Deleting the Arntl Clock Gene in Cortical Neurons.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/28052921","citation_count":31,"is_preprint":false},{"pmid":"31747713","id":"PMC_31747713","title":"Circadian BMAL1 regulates mandibular condyle development by hedgehog pathway.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31747713","citation_count":31,"is_preprint":false},{"pmid":"32522976","id":"PMC_32522976","title":"The circadian clock gene Bmal1 facilitates cisplatin-induced renal injury and hepatization.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32522976","citation_count":30,"is_preprint":false},{"pmid":"28721450","id":"PMC_28721450","title":"Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α.","date":"2017","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28721450","citation_count":30,"is_preprint":false},{"pmid":"37878694","id":"PMC_37878694","title":"Synaptic BMAL1 phosphorylation controls circadian hippocampal plasticity.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37878694","citation_count":29,"is_preprint":false},{"pmid":"36593479","id":"PMC_36593479","title":"Neural function of Bmal1: an overview.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36593479","citation_count":28,"is_preprint":false},{"pmid":"39106859","id":"PMC_39106859","title":"Hepatic BMAL1 and HIF1α regulate a time-dependent hypoxic response and prevent hepatopulmonary-like syndrome.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39106859","citation_count":27,"is_preprint":false},{"pmid":"30502053","id":"PMC_30502053","title":"H. pylori infection induced BMAL1 expression and rhythm disorder aggravate gastric inflammation.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/30502053","citation_count":27,"is_preprint":false},{"pmid":"30064996","id":"PMC_30064996","title":"The Clock Protein Bmal1 Regulates Circadian Expression and Activity of Sulfotransferase 1a1 in Mice.","date":"2018","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/30064996","citation_count":27,"is_preprint":false},{"pmid":"29943823","id":"PMC_29943823","title":"BMAL1 and CLOCK proteins in regulating UVB-induced apoptosis and DNA damage responses in human keratinocytes.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29943823","citation_count":27,"is_preprint":false},{"pmid":"34727291","id":"PMC_34727291","title":"BMAL1 induces colorectal cancer metastasis by stimulating exosome secretion.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/34727291","citation_count":26,"is_preprint":false},{"pmid":"40133642","id":"PMC_40133642","title":"Pharmacological targeting of BMAL1 modulates circadian and immune pathways.","date":"2025","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/40133642","citation_count":25,"is_preprint":false},{"pmid":"38032732","id":"PMC_38032732","title":"Neuronal deletion of the circadian clock gene Bmal1 induces cell-autonomous dopaminergic neurodegeneration.","date":"2024","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/38032732","citation_count":24,"is_preprint":false},{"pmid":"31958455","id":"PMC_31958455","title":"The role of circadian clock gene BMAL1 in vascular proliferation.","date":"2020","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31958455","citation_count":24,"is_preprint":false},{"pmid":"35311235","id":"PMC_35311235","title":"Critical Roles of the Circadian Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35311235","citation_count":23,"is_preprint":false},{"pmid":"35682995","id":"PMC_35682995","title":"Haploinsufficiency of a Circadian Clock Gene Bmal1 (Arntl or Mop3) Causes Brain-Wide mTOR Hyperactivation and Autism-like Behavioral Phenotypes in Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35682995","citation_count":22,"is_preprint":false},{"pmid":"33792447","id":"PMC_33792447","title":"The circadian clock gene Bmal1: Role in COVID-19 and periodontitis.","date":"2021","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/33792447","citation_count":21,"is_preprint":false},{"pmid":"35414779","id":"PMC_35414779","title":"BMAL1 regulates Propionibacterium acnes-induced skin inflammation via REV-ERBα in mice.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35414779","citation_count":21,"is_preprint":false},{"pmid":"34160901","id":"PMC_34160901","title":"Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells.","date":"2021","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/34160901","citation_count":21,"is_preprint":false},{"pmid":"34157911","id":"PMC_34157911","title":"Orthodontic Force-Induced BMAL1 in PDLCs Is a Vital Osteoclastic Activator.","date":"2021","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/34157911","citation_count":21,"is_preprint":false},{"pmid":"30341743","id":"PMC_30341743","title":"Deficiency of the clock gene Bmal1 affects neural progenitor cell migration.","date":"2018","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/30341743","citation_count":21,"is_preprint":false},{"pmid":"38678672","id":"PMC_38678672","title":"BMAL1 alleviates myocardial damage in sepsis by activating SIRT1 signaling and promoting mitochondrial autophagy.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38678672","citation_count":21,"is_preprint":false},{"pmid":"36977416","id":"PMC_36977416","title":"Behavioral circatidal rhythms require Bmal1 in Parhyale hawaiensis.","date":"2023","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/36977416","citation_count":21,"is_preprint":false},{"pmid":"37479181","id":"PMC_37479181","title":"Ceramide-1-phosphate alleviates high-altitude pulmonary edema by stabilizing circadian ARNTL-mediated mitochondrial dynamics.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/37479181","citation_count":20,"is_preprint":false},{"pmid":"31634367","id":"PMC_31634367","title":"BMAL1 associates with chromosome ends to control rhythms in TERRA and telomeric heterochromatin.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31634367","citation_count":20,"is_preprint":false},{"pmid":"38245503","id":"PMC_38245503","title":"Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38245503","citation_count":19,"is_preprint":false},{"pmid":"35779420","id":"PMC_35779420","title":"Bmal1-knockout mice exhibit reduced cocaine-seeking behaviour and cognitive impairments.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/35779420","citation_count":19,"is_preprint":false},{"pmid":"35933488","id":"PMC_35933488","title":"Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35933488","citation_count":18,"is_preprint":false},{"pmid":"24103761","id":"PMC_24103761","title":"DNA methylation of the BMAL1 promoter.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24103761","citation_count":18,"is_preprint":false},{"pmid":"30610898","id":"PMC_30610898","title":"Deficiency of Bmal1 disrupts the diurnal rhythm of haemostasis.","date":"2019","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/30610898","citation_count":18,"is_preprint":false},{"pmid":"38956298","id":"PMC_38956298","title":"Circadian disruption reduces MUC4 expression via the clock molecule BMAL1 during dry eye development.","date":"2024","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38956298","citation_count":17,"is_preprint":false},{"pmid":"32284354","id":"PMC_32284354","title":"BMAL1 coordinates energy metabolism and differentiation of pluripotent stem cells.","date":"2020","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/32284354","citation_count":17,"is_preprint":false},{"pmid":"37620297","id":"PMC_37620297","title":"Circadian clock regulator Bmal1 gates axon regeneration via Tet3 epigenetics in mouse sensory neurons.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37620297","citation_count":16,"is_preprint":false},{"pmid":"34520858","id":"PMC_34520858","title":"L-cell Arntl is required for rhythmic glucagon-like peptide-1 secretion and maintenance of intestinal homeostasis.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34520858","citation_count":16,"is_preprint":false},{"pmid":"32093736","id":"PMC_32093736","title":"Circadian expression of Fabp7 mRNA is disrupted in Bmal1 KO mice.","date":"2020","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/32093736","citation_count":16,"is_preprint":false},{"pmid":"33525630","id":"PMC_33525630","title":"Translational Regulation of Clock Genes BMAL1 and REV-ERBα by Polyamines.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33525630","citation_count":16,"is_preprint":false},{"pmid":"25799324","id":"PMC_25799324","title":"Depression-associated ARNTL and PER2 genetic variants in psychotic disorders.","date":"2015","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/25799324","citation_count":16,"is_preprint":false},{"pmid":"40127275","id":"PMC_40127275","title":"Control of circadian muscle glucose metabolism through the BMAL1-HIF axis in obesity.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40127275","citation_count":15,"is_preprint":false},{"pmid":"36942818","id":"PMC_36942818","title":"BMAL1 regulates osteoblast differentiation through mTOR/GSK3β/β-catenin pathway.","date":"2023","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36942818","citation_count":15,"is_preprint":false},{"pmid":"33130178","id":"PMC_33130178","title":"The clock regulator Bmal1 protects against muscular dystrophy.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33130178","citation_count":15,"is_preprint":false},{"pmid":"35338256","id":"PMC_35338256","title":"S6K1 controls adiponectin expression by inducing a transcriptional switch: BMAL1-to-EZH2.","date":"2022","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35338256","citation_count":15,"is_preprint":false},{"pmid":"26910317","id":"PMC_26910317","title":"Circadian adaptation to cell injury stresses: a crucial interplay of BMAL1 and HSF1.","date":"2016","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/26910317","citation_count":15,"is_preprint":false},{"pmid":"39552248","id":"PMC_39552248","title":"Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.","date":"2025","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/39552248","citation_count":14,"is_preprint":false},{"pmid":"39187065","id":"PMC_39187065","title":"BMAL1/PGC1α4-FNDC5/irisin axis impacts distinct outcomes of time-of-day resistance exercise.","date":"2024","source":"Journal of sport and health science","url":"https://pubmed.ncbi.nlm.nih.gov/39187065","citation_count":14,"is_preprint":false},{"pmid":"29357439","id":"PMC_29357439","title":"Circadian regulation of kidney function: finding a role for Bmal1.","date":"2017","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29357439","citation_count":14,"is_preprint":false},{"pmid":"38246330","id":"PMC_38246330","title":"Melatonin ameliorates hepatic fibrosis via the melatonin receptor 2-mediated upregulation of BMAL1 and anti-oxidative enzymes.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38246330","citation_count":14,"is_preprint":false},{"pmid":"37381033","id":"PMC_37381033","title":"Ziwuliuzhu Acupuncture Modulates Clock mRNA, Bmal1 mRNA and Melatonin in Insomnia Rats.","date":"2023","source":"Journal of acupuncture and meridian studies","url":"https://pubmed.ncbi.nlm.nih.gov/37381033","citation_count":14,"is_preprint":false},{"pmid":"39303541","id":"PMC_39303541","title":"BMAL1 alleviates sepsis-induced AKI by inhibiting ferroptosis.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39303541","citation_count":13,"is_preprint":false},{"pmid":"34341001","id":"PMC_34341001","title":"BMAL1 dephosphorylation determines the pace of the circadian clock.","date":"2021","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/34341001","citation_count":13,"is_preprint":false},{"pmid":"37657745","id":"PMC_37657745","title":"Denervation aggravates renal ischemia reperfusion injury via BMAL1-mediated Nrf2/ARE pathway.","date":"2023","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/37657745","citation_count":13,"is_preprint":false},{"pmid":"36563187","id":"PMC_36563187","title":"Melatonin upregulates BMAL1 to attenuate chronic sleep deprivation-related cognitive impairment by alleviating oxidative stress.","date":"2022","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/36563187","citation_count":13,"is_preprint":false},{"pmid":"33112769","id":"PMC_33112769","title":"Core clock gene Bmal1 deprivation impairs steroidogenesis in mice luteinized follicle cells.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33112769","citation_count":13,"is_preprint":false},{"pmid":"36180647","id":"PMC_36180647","title":"The circadian clock gene ARNTL overexpression suppresses oral cancer progression by inducing apoptosis via activating autophagy.","date":"2022","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36180647","citation_count":12,"is_preprint":false},{"pmid":"36602574","id":"PMC_36602574","title":"The circadian rhythm gene Bmal1 ameliorates acute deoxynivalenol-induced liver damage.","date":"2023","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36602574","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48557,"output_tokens":13143,"usd":0.171408,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":25146,"output_tokens":5198,"usd":0.12784,"stage2_stop_reason":"end_turn"},"total_usd":0.299248,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"GSK3β phosphorylates BMAL1 specifically on Ser17 and Thr21, priming it for ubiquitylation and proteasomal degradation. In the absence of GSK3β-mediated phosphorylation, BMAL1 is stabilized. Dopamine D2 receptor signaling via the Akt-GSK3β pathway regulates BMAL1 stability and circadian gene expression amplitude in striatal neurons.\",\n      \"method\": \"In vitro phosphorylation assays, site-directed mutagenesis (Ser17/Thr21), ubiquitylation assays, D2 receptor pharmacology in striatal neurons\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis identifying specific phosphorylation sites, combined with ubiquitylation assay and in vivo neuronal validation\",\n      \"pmids\": [\"20049328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CLOCK:BMAL1 heterodimer functions as a pioneer-like transcription factor: it binds to nucleosomes, promotes rhythmic chromatin opening (including incorporation of histone variant H2A.Z), and enables rhythmic binding of other transcription factors at adjacent sites, thereby driving genome-wide heterogeneous transcriptional output.\",\n      \"method\": \"ChIP-seq, ATAC-seq (chromatin accessibility), histone variant profiling, genome-wide binding analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genome-wide ChIP-seq with chromatin remodeling assays, multiple orthogonal methods establishing pioneer function\",\n      \"pmids\": [\"24395244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BMAL1 functions as a metabolic checkpoint in macrophages: upon M1 inflammatory stimulation, myeloid-specific Bmal1 KO renders macrophages unable to sustain mitochondrial function, enhancing succinate dehydrogenase (SDH)-mediated ROS production and HIF-1α-dependent metabolic reprogramming. This Bmal1-HIF-1α regulatory loop controls macrophage effector functions and tumor microenvironment.\",\n      \"method\": \"Myeloid-specific Bmal1 knockout (M-BKO), mitochondrial function assays, ROS measurement, HIF-1α activation assays, SDH inhibitor rescue experiments, tumor burden measurement\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple orthogonal metabolic readouts, genetic and pharmacological rescue, replicated in inflammatory and tumor contexts\",\n      \"pmids\": [\"32396064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BMAL1 forms a transcriptionally active heterodimer with HIF2A (a non-canonical partner) in a diurnal manner to regulate myocardial hypoxic response. Cryo-EM structure of the BMAL1-HIF2A-DNA complex reveals structural rearrangements within BMAL1 that enable circadian-hypoxia cross-talk. BMAL1 enhances HIF2A transcriptional activity and stabilizes the HIF2A protein. Amphiregulin (AREG) is identified as a rhythmic target of this complex, critical for daytime variations in myocardial injury.\",\n      \"method\": \"Cryo-EM structure determination, Co-IP, transcriptional activity assays, HIF2A protein stability assays, ChIP, cardiac ischemia models with time-of-day pharmacological targeting\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure plus biochemical validation of heterodimer, protein stabilization, and downstream target identification in a single rigorous study\",\n      \"pmids\": [\"40269168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The nuclear receptor HNF4A strongly transrepresses the transcriptional activity of the CLOCK:BMAL1 heterodimer and maintains cell-autonomous circadian oscillations in a tissue-specific manner in liver and colon cells. Genome-wide ChIP-seq reveals co-occupancy of HNF4A and CLOCK:BMAL1 at metabolic genes, defining a feedback loop in tissue-specific oscillators.\",\n      \"method\": \"Luciferase transcriptional activity assays, ChIP-seq (genome-wide co-occupancy), siRNA knockdown of HNF4A in liver and colon cells, circadian period measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal transcriptional assays plus genome-wide ChIP-seq, two orthogonal methods, single lab\",\n      \"pmids\": [\"30530698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BMAL1 plays a transcription-independent role in stabilizing heterochromatin to prevent activation of the LINE1-cGAS-STING pathway. In senescent primate mesenchymal progenitor cells (MPCs), BMAL1 binding to LINE1 loci is decreased, leading to heterochromatin destabilization and aberrant LINE1 transcription, accelerating aging phenotype.\",\n      \"method\": \"BMAL1 loss-of-function in human and cynomolgus monkey MPCs, chromatin fractionation, ChIP for BMAL1 at LINE1, cGAS-STING pathway activation assays, heterochromatin marker analysis in BMAL1-deficient monkey tissues\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — primate model with multiple orthogonal methods (ChIP, fractionation, pathway assays) in both cell and tissue contexts, establishes non-canonical chromatin function\",\n      \"pmids\": [\"35286396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BMAL1 in chondrocytes directs circadian expression of catabolic, anabolic, and apoptotic genes critical for cartilage homeostasis. Loss of chondrocyte BMAL1 reduces phosphorylated SMAD2/3 and NFATC2, decreases expression of Sox9, Acan, and Col2a1, and increases p-SMAD1/5 levels, causing progressive cartilage degeneration.\",\n      \"method\": \"Chondrocyte-specific Bmal1 knockout mice, RNA-seq, western blot for SMAD2/3 and SMAD1/5 phosphorylation, histological cartilage assessment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with molecular pathway analysis (SMAD phosphorylation) and histological phenotype, multiple orthogonal readouts\",\n      \"pmids\": [\"26657859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BMAL1 regulates macrophage actin cytoskeletal organization, motility, and phagocytosis via a RhoA-dependent mechanism. BMAL1-/- macrophages show reduced phosphocofilin, increased active RhoA, altered cell morphology and increased motility. BMAL1 controls a network of 148 cell movement genes within 100 kb of high-confidence BMAL1 binding sites, including 29 genes impacting RhoA expression or activation. RhoA inhibition restores phagocytic phenotype.\",\n      \"method\": \"Bmal1-/- macrophage characterization, phosphoproteomics, RhoA activity assay, phagocytosis assay in vivo and in vitro, RhoA inhibitor rescue, BMAL1 ChIP-seq for binding sites near cytoskeletal genes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — phosphoproteomics plus functional rescue plus ChIP-seq, multiple orthogonal methods establishing RhoA-mediated mechanism\",\n      \"pmids\": [\"31900362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BMAL1 rhythmically localizes to hippocampal synapses in a manner dependent on its phosphorylation at Ser42 (pBMAL1-S42). Synaptic pBMAL1(S42) regulates autophosphorylation of CaMKIIα and circadian rhythms of CaMKIIα-dependent molecular interactions and LTP, but not global rest/activity behavior.\",\n      \"method\": \"Immunofluorescence/subcellular fractionation of synaptic BMAL1, phospho-specific antibodies, electrophysiology (LTP), CaMKIIα autophosphorylation assays, Ser42 phosphorylation-state analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — synaptic fractionation with phospho-site specificity, electrophysiological readout (LTP), and CaMKIIα biochemistry, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"37878694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P2-HNF4α (an alternative isoform induced in hepatocellular carcinoma) represses BMAL1 (ARNTL) expression and causes nuclear-to-cytoplasmic re-localization of P1-HNF4α. Forced BMAL1 expression in HNF4α-positive HCC prevents tumor growth in vivo.\",\n      \"method\": \"Promoter reporter assays, immunofluorescence for BMAL1 localization, forced BMAL1 expression in HCC xenografts, isoform-specific expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — localization and in vivo rescue experiments, but mechanistic details of repression rely on expression correlations in addition to functional assays\",\n      \"pmids\": [\"30341289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Necdin stabilizes BMAL1 protein through SGT1-HSP90 chaperone machinery. Necdin interacts with BMAL1 (N-terminal fragment) and SGT1 (C-terminal fragment) as identified by yeast two-hybrid screening. Depletion of necdin or SGT1/HSP90 leads to BMAL1 degradation via the ubiquitin-proteasome system, altering clock gene expression and circadian rhythms.\",\n      \"method\": \"Yeast two-hybrid screening, Co-IP, domain mapping (N- and C-terminal fragments), HSP90 inhibitor treatment, proteasome inhibitor rescue, necdin-KO mouse behavioral and gene expression analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — yeast two-hybrid plus Co-IP plus proteasome inhibitor rescue plus KO phenotype, multiple orthogonal methods establishing chaperone-dependent stability mechanism\",\n      \"pmids\": [\"32667666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BMAL1 deficiency leads to increased mTORC1 activity both in vivo and in cell culture. mTORC1 inhibition with rapamycin increases lifespan of Bmal1-/- mice by 50%, placing BMAL1 as a negative regulator of mTORC1 signaling upstream of aging control.\",\n      \"method\": \"Bmal1-/- mice, mTORC1 activity assays (S6K phosphorylation), rapamycin treatment, lifespan measurement\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rapamycin rescue demonstrating epistasis, single lab\",\n      \"pmids\": [\"24481314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The RRE-mediated feedback regulation of Bmal1 (rhythmic transcription driven by REV-ERB/ROR elements) underpins the E-box-mediated core oscillation. Deletion of RRE elements in mutant mice produced apparently normal rhythms but made circadian period and amplitude more susceptible to disturbance of CRY1 protein rhythm, demonstrating that rhythmic Bmal1 transcription confers perturbation resistance to the clock.\",\n      \"method\": \"CRISPR deletion of RRE elements in cells and mice, circadian period/amplitude measurements, mathematical modeling, CRY1 protein manipulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genetic deletion with modeling and experimental validation, established in both cells and whole animals\",\n      \"pmids\": [\"35999195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 coordinates circadian MRP2 expression in the intestine by directly activating transcription of Dbp and Rev-erbα through E-box elements in their promoters, which in turn regulate Mrp2 via a D-box element. BMAL1 also negatively regulates E4BP4 (a Mrp2 repressor) via Rev-erbα, generating diurnal Mrp2 expression and time-dependent drug pharmacokinetics.\",\n      \"method\": \"Intestine-specific Bmal1 KO mice, qPCR, western blot, luciferase reporter assays, EMSA, ChIP assays for E-box binding, intestinal perfusion and pharmacokinetic experiments\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — EMSA, ChIP, reporter assays plus in vivo pharmacokinetics in conditional KO, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"31244920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 regulates circadian Cyp3a11 expression by directly activating Hnf4α and Dbp transcription via E-box elements. Cellular regulation of Cyp3a11 by BMAL1 is Dbp- and HNF4α-dependent, as Dbp activates and Hnf4α activates Cyp3a11 transcription via a D-box and DR1 element respectively in the Cyp3a11 promoter.\",\n      \"method\": \"Bmal1-deficient mice, luciferase reporter, ChIP, promoter mutation analysis, Dbp/Hnf4α overexpression/knockdown, drug toxicity assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP plus reporter plus mutagenesis plus in vivo KO, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"31633069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BMAL1 activates Sult1a1 transcription by directly binding an E-box element (-571 to -554 bp) in the Sult1a1 promoter, controlling circadian expression and activity of the sulfotransferase enzyme.\",\n      \"method\": \"Bmal1-deficient mice, luciferase reporter assay, EMSA, ChIP assay, serum-shocked cell circadian model\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — EMSA and ChIP plus reporter plus in vivo KO, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30064996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLOCK and BMAL1 cooperate to upregulate RHOA expression by inhibiting CUL3-mediated ubiquitination, and activate RHOA by reducing its interaction with RhoGDI. Consequently, CLOCK:BMAL1 controls the RHOA-ROCK-cofilin pathway, altering F-actin/G-actin dynamics and promoting cancer cell proliferation, migration, and invasion.\",\n      \"method\": \"Co-IP for RHOA-RhoGDI and CUL3 interactions, ubiquitination assay, F-actin/G-actin ratio measurement, CLOCK/BMAL1 overexpression and knockdown in cancer cells, cell migration and invasion assays\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus functional readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30287810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hepatic BMAL1 controls lipoprotein production and biliary cholesterol excretion by regulating expression of Mtp and Abcg5/Abcg8 via Shp and Gata4. BMAL1 deficiency reduces SHP (increasing MTP and lipoprotein secretion) and reduces GATA4 (diminishing ABCG5/8 expression and biliary cholesterol excretion). Forced SHP or GATA4 expression rescues respective phenotypes.\",\n      \"method\": \"Global and liver-specific Bmal1 KO mice on ApoE-/- and Ldlr-/- backgrounds, forced expression of SHP and GATA4, lipoprotein secretion assays, biliary cholesterol measurement, western blot/qPCR\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple KO models plus gain-of-function rescue experiments establishing genetic epistasis, replicated across multiple mouse backgrounds\",\n      \"pmids\": [\"27721414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMAL1 directly transactivates the Dgat2 gene (encoding triacylglycerol synthesis enzyme DGAT2) via direct binding to an E-box in the promoter, promoting dietary fat absorption. Intestinal Bmal1 deficiency impairs lipid resynthesis and reduces fat secretion; Rev-erbα deficiency (enhancing BMAL1 activity) exacerbates this.\",\n      \"method\": \"Intestine-specific Bmal1 KO mice, ChIP assay for E-box binding in Dgat2 promoter, luciferase reporter, lipid absorption assays, Rev-erbα intestinal KO\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP plus reporter plus conditional KO plus epistasis with Rev-erbα, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"34493722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"S6K1 phosphorylates BMAL1 at serine 42, causing its dissociation from the Adipoq promoter. This leads to EZH2 recruitment and H3K27me3 modification of the Adipoq promoter, suppressing adiponectin expression. Fasting inactivates S6K1, triggering an EZH2-to-BMAL1 transcriptional switch that promotes adiponectin expression.\",\n      \"method\": \"S6K1 kinase assay, ChIP for BMAL1 and EZH2/H3K27me3 at Adipoq promoter, S6K1 KO mice, phospho-Ser42 BMAL1 detection, promoter reporter assays\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — kinase assay identifying phosphorylation site plus ChIP for chromatin state plus in vivo KO, multiple orthogonal methods\",\n      \"pmids\": [\"35338256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Astrocyte-specific BMAL1 deletion induces Bag3 expression, a chaperone critical for macroautophagy, enhancing astrocyte phagocytosis of alpha-synuclein and tau in a BAG3-dependent manner. Astrocyte Bag3 overexpression is sufficient to mitigate alpha-synuclein spreading in vivo, placing BMAL1 upstream of BAG3-mediated protein clearance.\",\n      \"method\": \"Astrocyte-specific Bmal1 KO, Bag3 KO rescue experiments, Bag3 overexpression in vivo, phagocytosis assays for alpha-synuclein and tau, tauopathy and alpha-synucleinopathy mouse models\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with conditional KO plus BAG3 gain- and loss-of-function plus in vivo disease models, multiple orthogonal approaches\",\n      \"pmids\": [\"37315555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BMAL1 deletion in astrocytes influences endolysosomal function, autophagy, and protein degradation dynamics in a cell-autonomous manner. Bmal1-deficient astrocytes exhibit increased endocytosis, lysosome-dependent protein cleavage, and accumulation of LAMP1- and RAB7-positive organelles in vitro; astrocyte-specific Bmal1 KO brains show accumulation of autophagosome-like structures in vivo by electron microscopy. Transcriptional dysregulation of lysosome function pathways occurs independently of TFEB activation.\",\n      \"method\": \"Astrocyte-specific Bmal1 KO, electron microscopy, LAMP1/RAB7 immunostaining, endocytosis assays, lysosomal protease activity, RNA-seq of isolated astrocytes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with electron microscopy, organelle markers, functional assays, and transcriptomics, multiple orthogonal methods\",\n      \"pmids\": [\"37155839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BMAL1 cell-autonomously regulates astrocyte activation (astrogliosis) and inflammatory gene expression. Astrocyte-specific Bmal1 deletion induces astrocyte activation in vitro and in vivo, mediated in part by suppression of glutathione-S-transferase signaling. Loss of astrocyte BMAL1 promotes neuronal death in vitro.\",\n      \"method\": \"Astrocyte-specific Bmal1 KO (in vitro and in vivo), inflammatory gene expression profiling, glutathione-S-transferase pathway analysis, neuronal co-culture death assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with cell-autonomous pathway identification and functional neuronal death readout, multiple orthogonal methods\",\n      \"pmids\": [\"30282019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BMAL1 expression in skeletal muscle is both necessary and sufficient to regulate total sleep amount. Restoring Bmal1 only in skeletal muscle of Bmal1-KO mice rescued sleep-amount phenotypes; muscle-specific Bmal1 KO reproduced them. Overexpression of skeletal-muscle Bmal1 reduced the recovery response to sleep loss.\",\n      \"method\": \"Brain-specific and muscle-specific Bmal1 rescue in global KO mice, muscle-specific Bmal1 KO, polysomnographic sleep recording\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific rescue and KO with quantitative sleep phenotyping, multiple genetic approaches establishing necessity and sufficiency\",\n      \"pmids\": [\"28726633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Bmal1 inhibits axon regeneration of dorsal root ganglia neurons by acting as a gatekeeper of neuroepigenetic responses to axonal injury, limiting Tet3 expression and restricting 5-hydroxymethylcytosine (5hmC) modifications at regeneration-associated genes. Conditional neuronal Bmal1 deletion enhances axon regeneration in vitro and in vivo. Diurnal oscillation of Tet3 and 5hmC in DRG neurons corresponds to time-of-day effect on axon growth potential.\",\n      \"method\": \"Neuron-specific conditional Bmal1 KO, in vitro and in vivo neurite outgrowth assays, ChIP for 5hmC, RNA-seq, Tet3 expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with epigenetic ChIP, transcriptomics, and functional axon growth assays, multiple orthogonal methods\",\n      \"pmids\": [\"37620297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 directly binds the MITF promoter and transcriptionally regulates its expression, which positively influences melanin synthesis. BMAL1 overexpression increases MITF and melanin levels in human melanocytes/melanoma cells and protects against UVB-induced DNA damage.\",\n      \"method\": \"ChIP for BMAL1 at MITF promoter, luciferase reporter assay, BMAL1 overexpression/knockdown, melanin quantification, UVB treatment\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP and reporter assay plus functional melanin assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34160901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BMAL1 directly regulates neuronal survival in dopaminergic (TH+) neurons of the substantia nigra pars compacta in a cell-autonomous manner. Pan-neuronal or TH neuron-specific Bmal1 deletion caused spontaneous TH+ neuron loss. Transcriptomics revealed dysregulation of oxidative phosphorylation and Parkinson disease pathways.\",\n      \"method\": \"Cell-type-specific Cre-lox Bmal1 KO (pan-neuronal, TH-specific, astrocyte, microglia), stereological TH+ neuron counting, RNA-seq\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell-type-specific KO models establishing cell autonomy, with transcriptomic pathway analysis\",\n      \"pmids\": [\"38032732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMAL1 transcriptionally regulates Rab27a (a key exosome secretion gene) via luciferase assay, promoting exosome release from colorectal cancer cells and facilitating cancer cell migration.\",\n      \"method\": \"Luciferase reporter assay for Rab27a promoter, BMAL1 overexpression/knockdown, exosome isolation and quantification, migration assays\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Weak — luciferase assay plus functional exosome and migration readouts, single lab, single method for direct binding\",\n      \"pmids\": [\"34727291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Polyamines stimulate BMAL1 and REV-ERBα protein synthesis at the translational level through enhancement of ribosomal shunting within the 5'-UTR of their mRNAs. In polyamine-reduced cells, BMAL1 synthesis is reduced and circadian period is lengthened.\",\n      \"method\": \"EGFP fusion reporter with wild-type or mutated 5'-UTR of Bmal1 mRNA, polyamine depletion experiments, circadian period measurement in NIH3T3 cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — 5'-UTR mutational analysis in reporter assay plus polyamine depletion with functional period readout, single lab\",\n      \"pmids\": [\"33525630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 (ARNTL) associates with telomere DNA in a rhythmic/diurnal fashion in zebrafish and mice, and controls a circadian rhythm in TERRA (Telomeric Repeat-containing RNA). BMAL1-dependent H3K9me3 rhythm at telomeres is lost in aged animals, linking BMAL1 to telomere heterochromatin maintenance.\",\n      \"method\": \"ChIP for BMAL1 at telomere DNA, TERRA RT-qPCR in Bmal1-/- mouse liver, H3K9me3 ChIP at telomeres in zebrafish and mice, aging comparison\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct telomere binding plus KO validation plus aging comparison, single lab with multiple methods\",\n      \"pmids\": [\"31634367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMAL1 dephosphorylation by protein phosphatase 4 (PPP4) participates in modulating circadian timing and determines the pace of the circadian clock (as reviewed based on findings by Klemz et al.).\",\n      \"method\": \"Biochemical/genetic analysis of PPP4-mediated BMAL1 dephosphorylation (referenced in review/perspective based on original research)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — perspective/commentary article describing findings from another study; original experimental details not provided in this abstract\",\n      \"pmids\": [\"34341001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A small molecule (CCM) targeting the PASB domain cavity of BMAL1 causes expansion of the cavity, conformational changes in the PASB domain, and alters BMAL1 function as a transcription factor. CCM induces dose-dependent alterations in PER2-Luc oscillations and downregulates inflammatory and phagocytic pathways in macrophages. Crystal/structural and biochemical studies validate selectivity.\",\n      \"method\": \"Small molecule design, structural studies (BMAL1 PASB domain), biochemical binding assays, PER2-Luc reporter assay, macrophage inflammatory assays\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural plus biochemical plus cellular validation, multiple orthogonal methods identifying ligand-binding cavity in BMAL1 PASB domain\",\n      \"pmids\": [\"40133642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BMAL1 directly interacts with NF-κB p65 (RelA) subunit in theca cells and negatively regulates PI3K/NF-κB signaling, thereby controlling steroidogenesis-associated gene expression including Lhcgr, Hsd3β2, and Cyp17a1.\",\n      \"method\": \"Co-IP for BMAL1-RelA interaction, PI3K inhibitor rescue, siRNA-mediated Bmal1 knockdown in granulosa and theca cells, Bmal1 KO mice, hormone measurement\",\n      \"journal\": \"Reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP establishing direct interaction plus pharmacological and genetic rescue, single lab\",\n      \"pmids\": [\"33112769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 (ARNTL) acts as a transcription factor that suppresses NPC cell proliferation and enhances cisplatin sensitivity by directly binding the CDK5 promoter and activating CDK5 transcription, as validated by dual luciferase reporter and ChIP assays. CDK5 overexpression reverses the suppressive effects of BMAL1.\",\n      \"method\": \"Dual luciferase reporter assay for CDK5 promoter, ChIP assay, ARNTL overexpression and CDK5 overexpression epistasis experiment, proliferation and cisplatin sensitivity assays\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — luciferase and ChIP plus epistasis rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30621723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BMAL1 promotes OPC (oligodendrocyte precursor cell) proliferation in a time-of-day-dependent manner. OPC-specific Bmal1 KO disrupts circadian gene expression, proliferation, density, morphology, and migration, leading to thinner myelin and sleep fragmentation. In adults, OPC-specific Bmal1 loss impairs remyelination via changes in OPC morphology and migration.\",\n      \"method\": \"OPC-specific Bmal1 KO during development and adulthood, RNA-seq, immunostaining, electron microscopy for myelin thickness, demyelination lesion model, sleep recording\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in two temporal windows with multiple cellular, molecular, and functional readouts, single lab\",\n      \"pmids\": [\"37657440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BMAL1 binds the promoters of CCNA1 and CDK1 genes in endothelial cells (by ChIP-seq) and controls their expression, thereby regulating EC cell cycle progression. EC-specific BMAL1 impairment causes angiogenesis defects in neonatal vascular tissues and adult tumor angiogenesis settings.\",\n      \"method\": \"EC-specific Bmal1 KO in vivo, BMAL1 ChIP-seq in ECs, cell cycle analysis, angiogenesis assays (neonatal retina and tumor), RNA-seq\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-seq identifying direct target gene binding plus conditional KO with in vivo angiogenesis readouts, multiple orthogonal methods\",\n      \"pmids\": [\"37052172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Hepatic BMAL1 and HIF1α cooperate in the circadian response to hypoxia through shared and distinct regulatory roles. HIF1α accumulation upon hypoxia is temporally regulated and Bmal1-dependent. Loss of both hepatic Bmal1 and Hif1α causes hypoxemia, pulmonary vasodilation (via ERK-eNOS-NO), and mortality in a daytime-dependent manner, resembling hepatopulmonary syndrome.\",\n      \"method\": \"Liver-specific Bmal1 KO, liver-specific Hif1α KO, double KO, hypoxia exposure at different times of day, transcriptomics, eNOS/NO measurement, ERK activation assays\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple conditional KOs with mechanistic pathway analysis (ERK-eNOS-NO) and time-dependent mortality readout, multiple orthogonal methods\",\n      \"pmids\": [\"39106859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"LIN28A directly binds the BMAL1 promoter under H. pylori infection and activates BMAL1 transcription. In turn, BMAL1 functions as a transcription factor to enhance expression of proinflammatory TNF-α, promoting gastric inflammation.\",\n      \"method\": \"ChIP assay for LIN28A at BMAL1 promoter, dual luciferase reporter assay, H. pylori infection models in vitro and in vivo\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay establishing LIN28A-BMAL1-TNF-α axis, single lab with two orthogonal methods\",\n      \"pmids\": [\"30502053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BMAL1 non-canonically sequesters myosin heavy chain 9 (MYH9) to increase MRTF-SRF activity and AP-1 transcriptional signature, shifting melanoma cells from a Sox10-high to Sox9-high mesenchymal/immune-resistant cell state. This occurs independently of BMAL1's transcriptional activity, as a transcriptionally inactive BMAL1 mutant retains this function.\",\n      \"method\": \"Co-IP for BMAL1-MYH9 interaction, BMAL1 transcriptionally inactive mutant expression, MRTF-SRF reporter assays, scRNA-seq cell state analysis, tumor growth assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus transcriptionally inactive mutant establishing non-canonical function, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38245503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BMAL1 in cerebellar Purkinje cells (PCs) is required cell-autonomously for normal synaptic transmission and dendritic spine maturation. Bmal1 KO in PCs causes enhanced excitatory and inhibitory synaptic transmission, reduced PC firing, aberrant spine density/morphology, hyperactivated mTORC1 signaling, and autistic-like behaviors. Metformin reversal of mTORC1 hyperactivation rescues behavioral and cellular deficits.\",\n      \"method\": \"Global and PC-specific Bmal1 KO, electrophysiology, dendritic spine morphology, mTORC1 activity assays, metformin rescue, behavioral tests\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with electrophysiology, spine morphology, and pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"35301425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In skeletal muscle during diet-induced obesity, BMAL1 regulates HIF-driven glycolysis and metabolic flexibility. Muscle-specific BMAL1 deficiency impairs early glycolytic steps and worsens glucose tolerance. Genetic HIF1α stabilization in muscle Bmal1-deficient mice restores glucose tolerance and rescues 217/736 dysregulated genes, establishing BMAL1 upstream of HIF1α in muscle glucose metabolism.\",\n      \"method\": \"Muscle-specific Bmal1 KO, metabolite profiling, glucose tolerance tests, HIF1α genetic stabilization rescue, RNA-seq in high-fat diet conditions\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with metabolomics plus genetic HIF1α rescue establishing epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"40127275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BMAL1 directly activates Ptch1 and Ihh promoters (binding to their promoter regions), regulating hedgehog signaling in mandibular condylar chondrocytes. BMAL1 deficiency impairs sequential chondrocyte differentiation and endochondral ossification; hedgehog signaling activator rescues the short stature phenotype.\",\n      \"method\": \"ChIP for BMAL1 at Ptch1 and Ihh promoters, RNA-seq in Bmal1-/- mandibular condyle, hedgehog activator rescue of BMAL1-deficient phenotype, micro-CT and histology\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct promoter binding plus genetic rescue, single lab\",\n      \"pmids\": [\"31747713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPAR-γ trans-activates Slc1a5 via a response element in its promoter, driving glutamine/methionine uptake in adipocytes. Impaired PPAR-γ in obesity reduces SLC1A5 and glutamine/methionine, decreasing H3K27ac and H3K4me3 at the Bmal1 promoter and disrupting Bmal1 transcription.\",\n      \"method\": \"ChIP assay for H3K27ac and H3K4me3 at Bmal1 promoter, luciferase reporter for PPAR-γ/SLC1A5 axis, in vitro and in vivo glutamine/methionine supplementation, qPCR/western blot\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter plus metabolic rescue experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"35198059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DNA methylation of the BMAL1 promoter CpG islands silences circadian BMAL1 expression. Treatment with the demethylating agent 5-aza-2'-deoxycytidine recovers BMAL1 expression and circadian oscillation. Reporter gene assays confirm that transcriptional machinery for BMAL1 is active, and methylation (not promoter dysfunction) is the cause of silencing.\",\n      \"method\": \"Bisulfite sequencing of BMAL1 promoter CpG islands, 5-aza-dC treatment, luciferase reporter assay, qPCR for circadian oscillation recovery\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bisulfite sequencing plus reporter assay plus pharmacological demethylation rescue, single lab\",\n      \"pmids\": [\"24103761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BMAL1 promotes mitophagy via SIRT1 to alleviate myocardial injury in sepsis. BMAL1 knockdown inhibits SIRT1 and mitophagy-associated proteins; SIRT1 overexpression partially reverses effects of BMAL1 knockdown, placing BMAL1 upstream of SIRT1 in a pro-mitophagy pathway in cardiomyocytes.\",\n      \"method\": \"siRNA/shRNA Bmal1 knockdown and overexpression in H9C2 cells, SIRT1 overexpression rescue, mitophagy protein expression (western blot), apoptosis/ROS by flow cytometry, cecal ligation-puncture in vivo model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — genetic epistasis (SIRT1 rescue of Bmal1 KD) plus in vivo model, single lab\",\n      \"pmids\": [\"38678672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BMAL1 overexpression reduces YAP transcriptional activity and inhibits the Hippo signaling pathway in renal tubular epithelial cells; ChIP-qPCR identifies YAP as a direct BMAL1 target. YAP positively regulates ACSL4, promoting ferroptosis. Inhibiting YAP (by Verteporfin) reverses BMAL1-downregulation-induced ferroptosis.\",\n      \"method\": \"BMAL1 overexpression, ChIP-qPCR for BMAL1 at YAP promoter, Verteporfin rescue, ferroptosis markers, transcriptome sequencing, in vivo sepsis-AKI model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-qPCR plus epistasis rescue plus in vivo model, single lab\",\n      \"pmids\": [\"39303541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMAL1 (ARNTL) in EPIYA L-cells is required for rhythmic GLP-1 secretion; L-cell-specific Arntl KO reduces GLP-1 secretion at peak time points and impairs time-dependent GLP-1 release. L-cell Arntl disruption also alters intestinal CD4+ intraepithelial lymphocytes, proinflammatory cytokine expression, and colonic microbiome composition.\",\n      \"method\": \"Inducible L-cell-specific Arntl KO mice, oral glucose tolerance tests at ZT2 and ZT14, GLP-1 measurement, siRNA knockdown in mGLUTag cells, transcriptomic analysis, microbiome 16S rRNA sequencing\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO plus in vitro siRNA with functional secretion readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34520858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Circadian rhythm disruption (by melatonin receptor 1/AMPKβ1 pathway perturbation) impairs endochondral bone formation. Mechanistically, melatonin receptor 1 (MTR1) periodically activates AMPKβ1 phosphorylation, which destabilizes CRY1 and triggers BMAL1 expression, coordinating circadian rhythms of chondrocyte proliferation and matrix synthesis.\",\n      \"method\": \"Circadian disruption mouse models, AMPKβ1 agonist rescue, AMPKβ1 phosphorylation assays, CRY1 stability assays, BMAL1 expression analysis, bone formation histology\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection (AMPKβ1 agonist rescue) plus stability assays, single lab\",\n      \"pmids\": [\"35094018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Circadian disruption causes BMAL1 to suppress MUC4 expression in corneal epithelial cells, contributing to dry eye pathology. BMAL1 silencing reduces MUC4 expression and BMAL1 overexpression increases it in cultured human corneal epithelial cells in vitro. Genetic BMAL1 ablation in mice recapitulates MUC4 deficiency and dry eye disease.\",\n      \"method\": \"BMAL1 siRNA and overexpression in human corneal epithelial cells, Bmal1 KO mice, MUC4 protein/mRNA measurement, corneal surface assessment\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — in vitro gain/loss-of-function plus in vivo KO with functional readout, single lab\",\n      \"pmids\": [\"38956298\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BMAL1 is the obligate positive-arm transcription factor of the mammalian circadian clock that heterodimerizes with CLOCK (and non-canonically with HIF2A) to bind E-box elements as a pioneer-like factor, driving rhythmic gene expression across virtually all tissues; its activity and stability are regulated by post-translational modifications including GSK3β-mediated phosphorylation (Ser17/Thr21) triggering ubiquitin-proteasome degradation, S6K1-mediated phosphorylation (Ser42) causing promoter dissociation, synaptic phosphorylation (Ser42) gating hippocampal LTP, and PPP4-mediated dephosphorylation setting clock pace, while protein stability is further maintained by the necdin-SGT1-HSP90 chaperone machinery; beyond transcriptional roles, BMAL1 non-canonically stabilizes heterochromatin at LINE1 loci to suppress retrotransposon activation and sequesters MYH9 to modulate MRTF-SRF cytoskeletal signaling, and cell-type-specific functions include regulating macrophage mitochondrial metabolism and RhoA-dependent phagocytosis, astrocyte BAG3-mediated protein clearance and lysosomal function, skeletal muscle sleep regulation, OPC myelination, dopaminergic neuron survival, and hepatic lipid/drug metabolism through direct transcriptional control of targets including DGAT2, Cyp3a11, MRP2, SULT1A1, MITF, CDK1, and CCNA1.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BMAL1 is the obligate positive-arm transcription factor of the mammalian circadian clock, functioning as a pioneer-like factor that binds nucleosomes, promotes rhythmic chromatin opening with H2A.Z incorporation, and enables time-of-day binding of other transcription factors to generate genome-wide rhythmic output [#1]. Its rhythmic transcription is itself sustained by a REV-ERB/ROR (RRE) element feedback loop that confers resistance to perturbation of the core E-box oscillation [#12], while promoter CpG methylation can silence BMAL1 expression entirely [#43]. BMAL1 activity and abundance are tightly tuned by post-translational control: GSK3\\u03b2 phosphorylates Ser17/Thr21 to prime ubiquitin-proteasomal degradation downstream of dopamine D2 receptor signaling [#0], S6K1 phosphorylation of Ser42 drives promoter dissociation and an EZH2-dependent repressive chromatin switch [#19], synaptic Ser42 phosphorylation gates CaMKII\\u03b1-dependent hippocampal LTP [#8], and BMAL1 protein is stabilized by a necdin\\u2013SGT1\\u2013HSP90 chaperone module [#10]. As a transcription factor BMAL1 directly drives diverse tissue programs, activating metabolic and drug-handling targets including Dgat2, Cyp3a11, Sult1a1, and an intestinal Dbp/Rev-erb\\u03b1\\u2192Mrp2 cascade [#18, #14, #15, #13], and controlling cell-cycle, survival, and differentiation genes such as CDK1/CCNA1 in endothelial cells, MITF in melanocytes, and hedgehog effectors Ptch1/Ihh in chondrocytes [#35, #25, #41]. Beyond canonical CLOCK partnership, BMAL1 forms a non-canonical, diurnally regulated heterodimer with HIF2A\\u2014whose structure was resolved by cryo-EM\\u2014to stabilize HIF2A and drive the rhythmic hypoxic target AREG [#3], and it acts upstream of HIF1\\u03b1 in hepatic and skeletal-muscle hypoxia and glucose-metabolism programs [#36, #40]. BMAL1 also performs transcription-independent functions: it stabilizes heterochromatin at LINE1 loci to suppress the cGAS-STING pathway during aging [#5] and sequesters MYH9 to modulate MRTF-SRF cytoskeletal signaling and melanoma cell state [#38]. These activities underlie cell-type-specific roles spanning macrophage mitochondrial metabolism and RhoA-dependent phagocytosis [#2, #7], astrocyte BAG3-mediated protein clearance and endolysosomal function [#20, #21], skeletal-muscle control of sleep amount [#23], oligodendrocyte precursor proliferation and myelination [#34], and dopaminergic neuron survival [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Established that BMAL1 abundance is controlled by signal-driven phosphodegradation, linking neurotransmitter signaling to clock amplitude.\",\n      \"evidence\": \"In vitro kinase and ubiquitylation assays with Ser17/Thr21 mutagenesis and D2 receptor pharmacology in striatal neurons\",\n      \"pmids\": [\"20049328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating the ubiquitylation not defined here\", \"in vivo phosphorylation stoichiometry over the circadian cycle not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined how a single heterodimer generates heterogeneous genome-wide rhythms: CLOCK:BMAL1 acts as a pioneer-like factor remodeling chromatin to license other factors.\",\n      \"evidence\": \"Genome-wide ChIP-seq, ATAC-seq, and histone variant (H2A.Z) profiling\",\n      \"pmids\": [\"24395244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"chromatin remodelers recruited by BMAL1 not identified\", \"which secondary factors are licensed at each locus left open\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected hepatic BMAL1 to systemic lipid and cholesterol handling through defined intermediary transcription factors.\",\n      \"evidence\": \"Global and liver-specific Bmal1 KO on ApoE-/- and Ldlr-/- backgrounds with SHP/GATA4 gain-of-function rescue\",\n      \"pmids\": [\"27721414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct vs indirect regulation of Shp/Gata4 not fully resolved\", \"human relevance not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed BMAL1 transcriptional output is gated by tissue-specific repressors and reciprocal feedback in liver and colon oscillators.\",\n      \"evidence\": \"Reciprocal luciferase assays, genome-wide HNF4A/CLOCK:BMAL1 co-occupancy ChIP-seq, and HNF4A knockdown\",\n      \"pmids\": [\"30530698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism of HNF4A transrepression at chromatin not defined\", \"generalizability beyond liver/colon untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated that direct BMAL1 transcriptional targets extend to xenobiotic-handling enzymes, establishing a clock basis for drug pharmacokinetics.\",\n      \"evidence\": \"EMSA, ChIP, and luciferase reporters at the Sult1a1 E-box in Bmal1-deficient mice and serum-shocked cells\",\n      \"pmids\": [\"30064996\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single-site analysis; broader enzyme network not mapped\", \"human SULT1A1 regulation not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapped a multi-tier BMAL1 transcriptional cascade controlling intestinal drug transport and CYP enzyme rhythms.\",\n      \"evidence\": \"Intestine-specific Bmal1 KO with EMSA/ChIP/reporter and in vivo pharmacokinetics for Mrp2 and Cyp3a11\",\n      \"pmids\": [\"31244920\", \"31633069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative contribution of each intermediary (Dbp, Rev-erba, Hnf4a) in vivo not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a chaperone machinery that maintains BMAL1 protein stability, defining a post-translational input to clock pace independent of transcription.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP with domain mapping, HSP90/proteasome inhibitor rescue, and necdin-KO mouse phenotyping\",\n      \"pmids\": [\"32667666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how chaperone availability is itself regulated rhythmically not addressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed BMAL1 as a metabolic and cytoskeletal regulator in macrophages, linking the clock to mitochondrial function, HIF-1\\u03b1 reprogramming, and RhoA-dependent phagocytosis.\",\n      \"evidence\": \"Myeloid-specific Bmal1 KO with metabolic readouts, phosphoproteomics, RhoA activity assays, ChIP-seq, and pharmacological rescue\",\n      \"pmids\": [\"32396064\", \"31900362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether cytoskeletal control is transcriptional or post-translational in macrophages not fully separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established a transcription-independent genome-protective role for BMAL1 in heterochromatin maintenance at LINE1 elements during aging.\",\n      \"evidence\": \"BMAL1 loss-of-function in primate MPCs with chromatin fractionation, LINE1 ChIP, and cGAS-STING pathway assays\",\n      \"pmids\": [\"35286396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how BMAL1 is recruited to LINE1 heterochromatin not defined\", \"relationship to its E-box DNA binding unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed that rhythmic Bmal1 transcription via RRE elements buffers the clock against perturbation, defining the functional purpose of the auxiliary feedback loop.\",\n      \"evidence\": \"CRISPR deletion of RRE elements in cells and mice with mathematical modeling and CRY1 manipulation\",\n      \"pmids\": [\"35999195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular nature of the perturbation buffering not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined an S6K1-Ser42 phosphorylation switch that couples nutrient/fasting signaling to a BMAL1\\u2192EZH2 chromatin state change at metabolic gene promoters.\",\n      \"evidence\": \"S6K1 kinase assay, phospho-Ser42 detection, ChIP for BMAL1/EZH2/H3K27me3 at Adipoq, and S6K1 KO mice\",\n      \"pmids\": [\"35338256\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether the EZH2 switch operates at other BMAL1 targets genome-wide untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected BMAL1 to neuronal physiology through synaptic localization and cell-autonomous roles in protein clearance, axon regeneration, and synaptic maturation.\",\n      \"evidence\": \"Astrocyte-, neuron-, and Purkinje-cell-specific Bmal1 KO with synaptic fractionation, electrophysiology, BAG3/lysosomal assays, and 5hmC ChIP\",\n      \"pmids\": [\"37878694\", \"37315555\", \"37155839\", \"37620297\", \"35301425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"extent to which these roles are circadian vs constitutive not always separated\", \"direct BMAL1 target genes in each neural context only partially mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Positioned BMAL1 upstream of HIF1\\u03b1 in tissue hypoxia and glucose-metabolism programs through epistatic rescue.\",\n      \"evidence\": \"Liver and skeletal-muscle conditional Bmal1 KO with genetic HIF1\\u03b1 stabilization rescue, metabolomics, and time-dependent physiology\",\n      \"pmids\": [\"39106859\", \"40127275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular mechanism by which BMAL1 restrains HIF1\\u03b1 accumulation not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Resolved a non-canonical BMAL1-HIF2A heterodimer structurally and functionally, demonstrating direct circadian-hypoxia transcriptional cross-talk.\",\n      \"evidence\": \"Cryo-EM of the BMAL1-HIF2A-DNA complex with Co-IP, HIF2A stability assays, ChIP, and cardiac ischemia models\",\n      \"pmids\": [\"40269168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"genome-wide scope of BMAL1-HIF2A targets beyond AREG not mapped\", \"competition with CLOCK for BMAL1 not quantified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated that a small molecule binding the BMAL1 PASB cavity can allosterically reshape its transcription factor activity, validating BMAL1 as a directly druggable target.\",\n      \"evidence\": \"Small-molecule design with structural and biochemical binding studies, PER2-Luc oscillation readouts, and macrophage assays\",\n      \"pmids\": [\"40133642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"selectivity over related PAS-domain proteins in vivo not fully established\", \"therapeutic window unaddressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BMAL1 partitions between its canonical CLOCK-dependent transcriptional role and its transcription-independent functions (heterochromatin stabilization, MYH9 sequestration, HIF partnerships) within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no quantitative model of how BMAL1 pools are allocated among functions\", \"recruitment mechanisms to non-E-box sites undefined\", \"in vivo consequences of decoupling transcriptional from non-transcriptional roles untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 13, 14, 15, 18, 25, 33, 35, 41]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 5, 29]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [38]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 3, 19]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [5, 29]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [1, 12, 30]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 13, 14, 18, 35]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 5, 19]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [17, 18, 40]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3, 36, 40]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 7]}\n    ],\n    \"complexes\": [\"CLOCK:BMAL1 heterodimer\", \"BMAL1-HIF2A heterodimer\"],\n    \"partners\": [\"CLOCK\", \"HIF2A\", \"HNF4A\", \"MYH9\", \"NDN\", \"SGT1\", \"RELA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}